var title_f32_50_33568="Sq cell ca lung CT";
var content_f32_50_33568=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    His CT shows the mass with collapse of the lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33568=[""].join("\n");
var outline_f32_50_33568=null;
var title_f32_50_33569="Patient information: Sepsis in adults (The Basics)";
var content_f32_50_33569=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/23/37235\">",
"         Patient information: Fever in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Sepsis in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/sepsis-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H12436487\">",
"      <span class=\"h1\">",
"       What is sepsis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sepsis is a serious illness that happens when an infection affects the whole body in a certain way. Sepsis can happen in anyone, but it is more likely to happen in people who:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Are older or bedridden",
"       </li>",
"       <li>",
"        Are staying in the hospital or have had recent surgery",
"       </li>",
"       <li>",
"        Have thin tubes such as catheters or IVs in their body",
"       </li>",
"       <li>",
"        Have a weak infection-fighting system",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sepsis needs to be treated quickly. If it is not treated, it can become severe. Severe sepsis can lead to a life-threatening condition called &ldquo;septic shock.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436502\">",
"      <span class=\"h1\">",
"       What are the symptoms of sepsis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of sepsis can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A fever &ndash; But some people get a low body temperature instead of a fever.",
"       </li>",
"       <li>",
"        Chills",
"       </li>",
"       <li>",
"        Breathing that is very fast",
"       </li>",
"       <li>",
"        A heartbeat that is very fast",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms of severe sepsis can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Acting confused or feeling light-headed",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"       <li>",
"        Cool clammy skin or red flushed skin",
"       </li>",
"       <li>",
"        Urinating much less than usual",
"       </li>",
"       <li>",
"        Different types of skin rashes &ndash; One type is a lacy, purple rash that is usually on the legs, but can also be on the arms. Another rash looks like red or purple spots on the skin that do not go away when touched. These spots are usually on the chest and legs, but can also be in other areas.",
"       </li>",
"       <li>",
"        Other problems with the heart, kidneys, or brain",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People who have septic shock have many of the symptoms listed above, plus their blood pressure gets low.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436517\">",
"      <span class=\"h1\">",
"       Should I see the doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, as soon as possible. Many people who get sepsis are already in a hospital. But if you are not in a hospital, you (or the person with you) should call the doctor or nurse if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have a fever and chills, and have any of the symptoms above or look very sick",
"       </li>",
"       <li>",
"        Have had a recent surgery or hospital stay, and now are sick or have an infection",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your doctor or nurse is unable to see you immediately, or you can&rsquo;t reach him or her, you should go to the nearest emergency room.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436532\">",
"      <span class=\"h1\">",
"       Will I have tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Probably. Your doctor will learn about your symptoms and do an exam. He or she will likely do tests to look for an infection, see if the infection has spread to your blood, and see how serious your condition is. These tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests, including a test called &ldquo;blood cultures&rdquo;",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        Lab tests &ndash; For example, if you are coughing up mucus, your doctor can test your mucus for bacteria.",
"       </li>",
"       <li>",
"        X-rays or imaging tests &ndash; Imaging tests can create pictures of the inside of your body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436547\">",
"      <span class=\"h1\">",
"       How is sepsis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sepsis and septic shock are usually treated in the hospital with:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Antibiotics that go in your vein through an IV",
"       </li>",
"       <li>",
"        Fluids that go in your vein through an IV",
"       </li>",
"       <li>",
"        Other medicines to treat your condition &ndash; For example, if your blood pressure is too low, your doctor can give you medicine to raise it.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If an IV or catheter in your body is causing your sepsis, your doctor might take the IV or catheter out.",
"     </p>",
"     <p>",
"      Some people are also treated with surgery. If you have a severe infection of the skin or tissue under the skin, your doctor might do surgery to remove the infected areas.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436562\">",
"      <span class=\"h1\">",
"       Can sepsis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can help prevent sepsis by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Getting treated right away if you get an infection",
"       </li>",
"       <li>",
"        Avoiding infections &ndash; One way to avoid infections is to get the vaccines your doctor recommends. Vaccines are treatments that can prevent serious infections. If you have a child, make sure he or she gets the recommended vaccines, too.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12436577\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=see_link\">",
"       Patient information: Fever in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?32/50/33569?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16928 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33569=[""].join("\n");
var outline_f32_50_33569=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436487\">",
"      What is sepsis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436502\">",
"      What are the symptoms of sepsis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436517\">",
"      Should I see the doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436532\">",
"      Will I have tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436547\">",
"      How is sepsis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436562\">",
"      Can sepsis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12436577\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=related_link\">",
"      Patient information: Fever in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33570="Patient information: Vaginal discharge in adults (The Basics)";
var content_f32_50_33570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15593\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/10/160\">",
"         Adult female external genitalia",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?21/56/22402\">",
"         Patient information: Bacterial vaginosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/52/23362\">",
"         Patient information: Chlamydia and gonorrhea (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/1/14354\">",
"         Patient information: Vaginal yeast infection (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/43/36529\">",
"         Patient information: Bacterial vaginosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/14/24802\">",
"         Patient information: Chlamydia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/44/1730\">",
"         Patient information: Gonorrhea (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/44/40641\">",
"         Patient information: Vaginal discharge in adult women (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/53/2899\">",
"         Patient information: Vaginal yeast infection (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Vaginal discharge in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/vaginal-discharge-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1664912497\">",
"      <span class=\"h1\">",
"       What is vaginal discharge?",
"      </span>",
"      &nbsp;&mdash;&nbsp;&ldquo;Vaginal discharge&rdquo; is the term doctors use to describe the fluid that comes out of the vagina (",
"      <a class=\"graphic graphic_figure graphicRef53704 \" href=\"UTD.htm?0/10/160\">",
"       figure 1",
"      </a>",
"      ). Vaginal discharge is made up of cells from the vagina and cervix, bacteria, mucus, and water.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912504\">",
"      <span class=\"h1\">",
"       Can vaginal discharge be normal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Normally, women who get monthly periods can have a small amount of vaginal discharge each day. Normal vaginal discharge can be white, clear, or thick, but usually does not smell bad.",
"     </p>",
"     <p>",
"      Different women can have different amounts of vaginal discharge. Also, a woman can have more or less vaginal discharge at different times. For example, a woman might notice more vaginal discharge:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        When she is pregnant",
"       </li>",
"       <li>",
"        When she uses hormone birth control medicines",
"       </li>",
"       <li>",
"        During the two weeks before she gets her period",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Women who have been through menopause usually have less vaginal discharge. Menopause is the time when a woman stops getting her monthly period.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912511\">",
"      <span class=\"h1\">",
"       When is vaginal discharge abnormal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Vaginal discharge is abnormal when it occurs with the following symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Itching of the vagina or the area around the vagina",
"       </li>",
"       <li>",
"        Redness, pain, or swelling around the vagina",
"       </li>",
"       <li>",
"        Discharge that is foamy, greenish-yellow, or has blood in it",
"       </li>",
"       <li>",
"        Discharge that smells bad",
"       </li>",
"       <li>",
"        Pain when urinating or having sex",
"       </li>",
"       <li>",
"        Pain in the lower part of the belly",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912518\">",
"      <span class=\"h1\">",
"       What are the causes of abnormal vaginal discharge?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different conditions can cause abnormal vaginal discharge. The most common causes are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        An infection in the vagina",
"       </li>",
"       <li>",
"        A reaction to something in the vagina that a woman forgot to take out, such as a tampon or condom",
"       </li>",
"       <li>",
"        A reaction to a soap or other product that was in the vagina",
"       </li>",
"       <li>",
"        Changes in the body that occur after menopause",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912525\">",
"      <span class=\"h1\">",
"       Should I treat abnormal vaginal discharge myself?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. Most doctors recommend that you do not treat abnormal vaginal discharge yourself. Treating yourself can cause your symptoms to get worse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912532\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have abnormal vaginal discharge, see a doctor or nurse so that he or she can figure out the cause. Your doctor or nurse will talk with you and do an exam. He or she will also take a sample of your vaginal discharge, and do lab tests on the sample to look for an infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912539\">",
"      <span class=\"h1\">",
"       How is abnormal vaginal discharge treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment will depend on the cause of the abnormal vaginal discharge. For example, different vaginal infections are treated with different medicines. If you have a vaginal infection, your doctor or nurse will want to figure out what type of infection you have so that he or she can treat it with the right medicine.",
"     </p>",
"     <p>",
"      If your abnormal vaginal discharge is caused by certain types of infections, your sex partner will also need to see a doctor for treatment. (You might want to stop having sex until you know what is causing your symptoms.)",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912546\">",
"      <span class=\"h1\">",
"       Can abnormal vaginal discharge be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. You can help prevent abnormal vaginal discharge by:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Using warm water and unscented non-soap cleanser to wash your vulva (the vulva is the area of skin around the outside of the vagina)",
"       </li>",
"       <li>",
"        Taking baths in plain warm water, and not using scented bath products",
"       </li>",
"       <li>",
"        Wearing cotton underwear, and not wearing underwear or pants that are too tight",
"       </li>",
"       <li>",
"        Not using sprays or powders on your vagina",
"       </li>",
"       <li>",
"        Not douching (douching is when a woman puts a liquid inside her vagina to rinse it out)",
"       </li>",
"       <li>",
"        Not wiping with baby wipes or scented toilet paper after you use the toilet",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1664912553\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/56/22402?source=see_link\">",
"       Patient information: Bacterial vaginosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/1/14354?source=see_link\">",
"       Patient information: Vaginal yeast infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/52/23362?source=see_link\">",
"       Patient information: Chlamydia and gonorrhea (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40641?source=see_link\">",
"       Patient information: Vaginal discharge in adult women (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/43/36529?source=see_link\">",
"       Patient information: Bacterial vaginosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/53/2899?source=see_link\">",
"       Patient information: Vaginal yeast infection (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=see_link\">",
"       Patient information: Chlamydia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"       Patient information: Gonorrhea (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?32/50/33570?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15593 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-210.101.131.231-1C6C0C3C8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33570=[""].join("\n");
var outline_f32_50_33570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912497\">",
"      What is vaginal discharge?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912504\">",
"      Can vaginal discharge be normal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912511\">",
"      When is vaginal discharge abnormal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912518\">",
"      What are the causes of abnormal vaginal discharge?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912525\">",
"      Should I treat abnormal vaginal discharge myself?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912532\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912539\">",
"      How is abnormal vaginal discharge treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912546\">",
"      Can abnormal vaginal discharge be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1664912553\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15593\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/10/160\">",
"      Adult female external genitalia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/43/36529?source=related_link\">",
"      Patient information: Bacterial vaginosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/56/22402?source=related_link\">",
"      Patient information: Bacterial vaginosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/52/23362?source=related_link\">",
"      Patient information: Chlamydia and gonorrhea (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40641?source=related_link\">",
"      Patient information: Vaginal discharge in adult women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/53/2899?source=related_link\">",
"      Patient information: Vaginal yeast infection (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/1/14354?source=related_link\">",
"      Patient information: Vaginal yeast infection (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33571="Docusate: Pediatric drug information";
var content_f32_50_33571=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Docusate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?21/41/22165?source=see_link\">",
"    see \"Docusate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/14/8420?source=see_link\">",
"    see \"Docusate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F162174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Colace&reg; [OTC];",
"     </li>",
"     <li>",
"      Correctol&reg; [OTC];",
"     </li>",
"     <li>",
"      Diocto [OTC];",
"     </li>",
"     <li>",
"      Doc-Q-Lace [OTC];",
"     </li>",
"     <li>",
"      Docu-Soft [OTC];",
"     </li>",
"     <li>",
"      DocuSoft S&trade; [OTC];",
"     </li>",
"     <li>",
"      Dok&trade; [OTC];",
"     </li>",
"     <li>",
"      DSS&reg; [OTC];",
"     </li>",
"     <li>",
"      Dulcolax&reg; Stool Softener [OTC];",
"     </li>",
"     <li>",
"      Dulcolax&reg; [OTC];",
"     </li>",
"     <li>",
"      Enemeez&reg; Plus [OTC];",
"     </li>",
"     <li>",
"      Enemeez&reg; [OTC];",
"     </li>",
"     <li>",
"      Fleet&reg; Pedia-Lax&trade; Liquid Stool Softener [OTC];",
"     </li>",
"     <li>",
"      Fleet&reg; Sof-Lax&reg; [OTC];",
"     </li>",
"     <li>",
"      Kao-Tin [OTC];",
"     </li>",
"     <li>",
"      Kaopectate&reg; Stool Softener [OTC];",
"     </li>",
"     <li>",
"      Phillips'&reg; Liquid-Gels&reg; [OTC];",
"     </li>",
"     <li>",
"      Phillips'&reg; Stool Softener Laxative [OTC];",
"     </li>",
"     <li>",
"      Silace [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F162175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Docusate-Sodium&reg;;",
"     </li>",
"     <li>",
"      Colace&reg;;",
"     </li>",
"     <li>",
"      Colax-C&reg;;",
"     </li>",
"     <li>",
"      Novo-Docusate Calcium;",
"     </li>",
"     <li>",
"      Novo-Docusate Sodium;",
"     </li>",
"     <li>",
"      PMS-Docusate Calcium;",
"     </li>",
"     <li>",
"      PMS-Docusate Sodium;",
"     </li>",
"     <li>",
"      Regulex&reg;;",
"     </li>",
"     <li>",
"      Selax&reg;;",
"     </li>",
"     <li>",
"      Soflax&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1047042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Laxative, Surfactant",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Stool Softener",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1047038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/41/22165?source=see_link\">",
"      see \"Docusate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children: Oral: 5 mg/kg/day in 1-4 divided doses",
"     <b>",
"      or",
"     </b>",
"     dose by age:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;3 years: 10-40 mg/day in 1-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-6 years: 20-60 mg/day in 1-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6-12 years: 40-150 mg/day in 1-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adolescents and Adults: Oral: 50-400 mg/day in 1-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Older Children and Adults: Rectal: Add 50-100 mg of docusate liquid (not syrup) to enema fluid (NS or water)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F162159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Colace&reg;: 50 mg [contains sodium 3 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Colace&reg;: 100 mg [contains sodium 5 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Doc-Q-Lace: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, liquid, oral, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DocuSoft S&trade;: 100 mg [contains sodium 5 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral, as calcium: 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kao-Tin: 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kaopectate&reg; Stool Softener: 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral, as sodium: 50 mg, 100 mg, 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Correctol&reg;: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Docu-Soft: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dok&trade;: 100 mg, 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DSS&reg;: 100 mg, 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulcolax&reg;: 100 mg [contains sodium 5 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulcolax&reg; Stool Softener: 100 mg [contains sodium 5 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Sof-Lax&reg;: 100 mg [contains sodium 5 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Liquid-Gels&reg;: 100 mg [contains sodium 5.2 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phillips'&reg; Stool Softener Laxative: 100 mg [contains sodium 5.2 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral, as sodium: 50 mg/5 mL (10 mL, 25 mL, 473 mL [DSC]); 150 mg/15 mL (480 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diocto: 150 mg/15 mL (480 mL [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diocto: 150 mg/15 mL (473 mL) [contains propylene glycol, sodium 15 mg/15 mL; vanilla flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Pedia-Lax&trade; Liquid Stool Softener: 50 mg/15 mL (118 mL) [contains propylene glycol, sodium 13 mg/15 mL; fruit-punch flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Silace: 150 mg/15 mL (473 mL) [lemon-vanilla flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, rectal, as sodium [enema]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enemeez&reg;: 283 mg/5 mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enemeez&reg; Plus: 283 mg/5 mL (5 mL) [contains benzocaine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral, as sodium: 20 mg/5 mL (25 mL, 473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Colace&reg;: 60 mg/15 mL (473 mL) [ethanol free, sugar free; contains propylene glycol, sodium 34 mg/15 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diocto: 60 mg/15 mL (473 mL) [contains menthol, sodium 12 mg/15 mL, sodium benzoate; mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Doc-Q-Lace: 60 mg/15 mL (480 mL) [contains propylene glycol; peppermint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Silace: 60 mg/15 mL (480 mL) [peppermint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as sodium: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dok&trade;: 100 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F162145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes enema",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1047046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer docusate liquid (not syrup) with milk, fruit juice, or infant formula to mask the bitter taste; ensure adequate fluid intake",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Administer as a retention or flushing enema",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1047045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stool softener in patients who should avoid straining during defecation; constipation associated with hard, dry stools; ceruminolytic",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F162214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Colace&reg; may be confused with Calan&reg;, Cozaar&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dulcolax&reg; (docusate) may be confused with Dulcolax&reg; (bisacodyl)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Docusate may be confused with Doxinate brand name for doxylamine and pyridoxine [India]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F162212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramping, diarrhea, Intestinal obstruction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Throat irritation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1047049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to docusate or any component; concomitant use of mineral oil; intestinal obstruction, acute abdominal pain, nausea, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6219958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13888218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Short-term use of docusate is generally considered safe during pregnancy (Mahadevan, 2006). Hypomagnesemia was reported in a newborn following chronic maternal overuse throughout pregnancy (Schindler, 1984).",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1047037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduces surface tension of the oil-water interface of the stool resulting in enhanced incorporation of water and fat allowing for stool softening",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1047048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action: 12-72 hours",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1047050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Docusate sodium 5-10 mg/mL",
"     <b>",
"      liquid",
"     </b>",
"     instilled in the ear as a ceruminolytic produces substantial ear wax disintegration within 15 minutes and complete disintegration after 24 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chen DA and Caparosa RJ, &ldquo;A Nonprescription Cerumenolytic,&rdquo;",
"      <i>",
"       Am J Otol",
"      </i>",
"      , 1991, 12(6):475-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?32/50/33571/abstract-text/1725243/pubmed\" id=\"1725243\" target=\"_blank\">",
"        1725243",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13244 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-E8883B2495-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33571=[""].join("\n");
var outline_f32_50_33571=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162174\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162175\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047042\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047038\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162159\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162145\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047046\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047045\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162214\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162212\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047049\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299225\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6219958\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13888218\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047037\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047048\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047050\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13244\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13244|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/41/22165?source=related_link\">",
"      Docusate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/14/8420?source=related_link\">",
"      Docusate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33572="Resectoscope";
var content_f32_50_33572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 503px\">",
"   <div class=\"ttl\">",
"    Hysteroscopy: resectoscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 483px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Assembled hysteroscopic resectoscope with (B) roller bar and (C) roller ball.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33572=[""].join("\n");
var outline_f32_50_33572=null;
var title_f32_50_33573="Prochlorperazine: Patient drug information";
var content_f32_50_33573=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Prochlorperazine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/28/22984?source=see_link\">",
"     see \"Prochlorperazine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/14/5351?source=see_link\">",
"     see \"Prochlorperazine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F213829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Compro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F213830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Prochlorperazine&reg;;",
"     </li>",
"     <li>",
"      Nu-Prochlor;",
"     </li>",
"     <li>",
"      PMS-Prochlorperazine;",
"     </li>",
"     <li>",
"      Sandoz-Prochlorperazine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691728",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat upset stomach and throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700962",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give to a child younger than 2 years of age or weighing less than 20 pounds (9 kilograms).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702799",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to prochlorperazine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Reye's syndrome.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701537",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to any type of nuts or seeds, talk with your doctor. Some products have nuts in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use suppository rectally.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10994 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.102.30.19-471417A096-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33573=[""].join("\n");
var outline_f32_50_33573=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213829\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213830\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020189\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020191\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020190\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020195\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020196\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020198\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020193\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020194\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020199\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020200\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/28/22984?source=related_link\">",
"      Prochlorperazine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/14/5351?source=related_link\">",
"      Prochlorperazine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33574="Lidocaine (topical): Pediatric drug information";
var content_f32_50_33574=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lidocaine (topical): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=see_link\">",
"    see \"Lidocaine (topical): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?28/46/29413?source=see_link\">",
"    see \"Lidocaine (topical): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8768584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AneCream&reg; [OTC];",
"     </li>",
"     <li>",
"      Anestafoam&trade; [OTC] [DSC];",
"     </li>",
"     <li>",
"      Band-Aid&reg; Hurt Free&trade; Antiseptic Wash [OTC];",
"     </li>",
"     <li>",
"      Burn Jel Plus [OTC];",
"     </li>",
"     <li>",
"      Burn Jel&reg; [OTC];",
"     </li>",
"     <li>",
"      L-M-X&reg; 4 [OTC];",
"     </li>",
"     <li>",
"      L-M-X&reg; 5 [OTC];",
"     </li>",
"     <li>",
"      LidaMantle&reg; [DSC];",
"     </li>",
"     <li>",
"      Lidoderm&reg;;",
"     </li>",
"     <li>",
"      LidoPatch&trade; [OTC];",
"     </li>",
"     <li>",
"      LTA&reg; 360;",
"     </li>",
"     <li>",
"      Premjact&reg;;",
"     </li>",
"     <li>",
"      RectiCare&trade; [OTC];",
"     </li>",
"     <li>",
"      Regenecare&reg;;",
"     </li>",
"     <li>",
"      Regenecare&reg; HA [OTC];",
"     </li>",
"     <li>",
"      Solarcaine&reg; cool aloe Burn Relief [OTC];",
"     </li>",
"     <li>",
"      Topicaine&reg; [OTC];",
"     </li>",
"     <li>",
"      Unburn&reg; [OTC];",
"     </li>",
"     <li>",
"      Xylocaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8768585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Betacaine&reg;;",
"     </li>",
"     <li>",
"      Lidodan&trade;;",
"     </li>",
"     <li>",
"      Lidoderm&reg;;",
"     </li>",
"     <li>",
"      Maxilene&reg;;",
"     </li>",
"     <li>",
"      Xylocaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10529567\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Transdermal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12675240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Anesthetic, topical: Cream: L-M-X&reg; 4: Circumcision: Full-term neonates: Apply 2 g of cream (80 mg lidocaine) to foreskin and penis; occlude with plastic wrap; leave on for 20 minutes (Lehr, 2005)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10529633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=see_link\">",
"      see \"Lidocaine (topical): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Anesthetic, topical:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     LidaMantle&reg;: Skin irritation: Children and Adults: Apply a thin film to affected area 2-3 times/day as needed; reduce dose in pediatric patients according to age, body weight, and physical condition",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     L-M-X&reg; 4: Skin irritation: Children &ge;2 years and Adults: Apply up to 3-4 times/day to intact skin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     L-M-X&reg; 5: Relief of anorectal pain and itching: Children &ge;12 years and Adults: Apply to affected area up to 6 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gel, ointment: Children &ge;2 years and Adults: Apply to affected area up to 3-4 times/day as needed (maximum dose: 4.5 mg/kg, not to exceed 300 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical solution: Adults: Apply 1-5 mL (40-200 mg) to affected area",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Jelly:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: Dose varies with age and weight; maximum dose: 4.5 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: Maximum dose: 30 mL (600 mg) in any 12-hour period",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Anesthesia of urethra: Male: 5-30 mL (100-600 mg); Female: 3-5 mL (60-100 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Lubrication of endotracheal tube: Apply a moderate amount to external surface only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral solution (viscous): Dose should be adjusted according to patient&rsquo;s age, weight, and physical condition:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants and Children &lt;3 years: 1.25 mL applied to area with a cotton-tipped applicator no more frequently than every 3 hours (maximum: 4 doses per 12-hour period)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;3 years: Do not exceed 4.5 mg/kg/dose (or 300 mg/dose); swished in the mouth and spit out no more frequently than every 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Anesthesia of the mouth: 15 mL swished in the mouth and spit out no more frequently than every 3 hours (maximum: 8 doses per 24-hour period)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Anesthesia of the pharynx: 15 mL gargled no more frequently than every 3 hours (maximum: 8 doses per 24-hour period); may be swallowed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical patch (Lidoderm&reg; patch): Adults: Postherpetic neuralgia: Apply patch to most painful areas; up to 3 patches may be applied per application; patch(es) may remain in place for up to 12 hours in any 24-hour period",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8768875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, foam, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anestafoam&trade;: 4% (30 g [DSC]) [contains benzalkonium chloride, benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, spray, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Solarcaine&reg; cool aloe Burn Relief: 0.5% (127 g) [contains aloe, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     L-M-X&reg; 5: 5% (15 g, 30 g) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AneCream&reg;: 4% (5 g, 15 g, 30 g) [contains benzyl alcohol, soybean lecithin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     L-M-X&reg; 4: 4% (5 g, 15 g, 30 g) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     RectiCare&trade;: 5% (30 g) [contains benzyl alcohol, natural rubber/natural latex in packaging, propylene glycol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as hydrochloride: 0.5% (0.9 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LidaMantle&reg;: 3% (85 g [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Topicaine&reg;: 4% (10 g, 30 g, 113 g); 5% (10 g, 30 g, 113 g) [contains aloe, benzyl alcohol, ethanol 35%, jojoba]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Burn Jel Plus: 2.5% (118 mL) [contains vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Burn Jel&reg;: 2% (59 mL, 118 mL); 2% (3.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Regenecare&reg;: 2% (14 g, 85 g) [contains aloe; contains calcium alginate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Regenecare&reg; HA: 2% (85 g) [contains aloe; contains hyaluronic acid]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Solarcaine&reg; cool aloe Burn Relief: 0.5% (113 g, 226 g) [contains aloe, isopropyl alcohol, menthol, tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Unburn&reg;: 2.5% (59 mL) [contains vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Jelly, topical, as hydrochloride: 2% (5 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Jelly, topical, as hydrochloride [preservative free]: 2% (5 mL, 10 mL, 20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical: 5% (35.4 g, 50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lidoderm&reg;: 5% (30s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LidoPatch&trade;: 3.99% (3s) [contains menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premjact&reg;: 9.6% (13 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical, as hydrochloride: 4% [40 mg/mL] (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Band-Aid&reg; Hurt Free&trade; Antiseptic Wash: 2% [20 mg/mL] (177 mL) [contains aloe, benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LTA&reg; 360: 4% [40 mg/mL] (4 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xylocaine&reg;: 4% [40 mg/mL] (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical, as hydrochloride [preservative free]: 4% [40 mg/mL] (4 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, viscous, oral topical, as hydrochloride: 2% [20 mg/mL] (20 mL, 100 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8768595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Hydrochloride cream, jelly, ointment, solution",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10529684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel (Topicaine&reg;): Apply a moderately thick layer to affected area (~",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      8",
"     </sub>",
"     \" thick). Allow time for numbness to develop (~20-60 minutes after application). When used prior to laser surgery, avoid mucous membranes; remove prior to laser treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral solution (viscous): Have patient swish medication around mouth and then spit it out; for pharyngeal anesthesia, patient should gargle and may swallow medication.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical patch: Apply patch to intact skin so most painful area is covered; do not apply to broken or inflamed skin. Patch may be cut to appropriate size prior to removal of release liner. Remove immediately if burning sensation occurs. Wash hands after applying patch; avoid eye contact. Avoid exposing application site to external heat sources (eg, electric blankets, heating pads, heated water beds, heat lamps, tanning lamps, hot tubs, hot baths, saunas, sunbathing). Keep used and unused patches out of the reach of children; fold used patch so adhesive side sticks to itself; dispose of used patch properly.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10529628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     All formulations: Store at controlled room temperature; see product-specific labeling for any additional storage requirements.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10529604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Local anesthetic for oral mucous membrane; laser/cosmetic surgeries; minor burns, cuts, and abrasions of the skin (FDA approved in adults; refer to product specific information regarding FDA approval in pediatric patients)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical patch (Lidoderm&reg;): Relief of allodynia (painful hypersensitivity) and  postherpetic neuralgia (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rectal (L-M-X&reg; 5): Temporary relief of pain and itching due to anorectal disorders (FDA approved in ages &ge;12 years and adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral solution (viscous): Topical anesthesia of irritated oral mucous membranes and pharyngeal tissue (FDA approved in infants, children, and adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8768638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Adverse effects vary with formulation and extent of systemic absorption; children may be at increased risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cyanosis, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, confusion, dizziness, lethargy, lightheadedness, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, bruising (topical patch), contact dermatitis, depigmentation (topical patch), edema of the skin, itching, petechia (topical patch), pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Methemoglobinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Irritation (topical patch)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Pain exacerbation (topical patch), paresthesia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Hypoxia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Pain exacerbation (topical patch)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10529624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to lidocaine, amide-type local anesthetics, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10529626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hepatic disease or heart failure.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10529625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical anesthetic use prior to cosmetic or other medical procedures can result in high systemic levels and lead to toxic effects (eg, arrhythmias, methemoglobinemia, seizures, coma, respiratory depression, death). Children may be at an increased risk for adverse effects. Toxic effects may occur, particularly when topical anesthetics are applied in large amounts or to large areas of the skin; left on for long periods of time; used with materials, wraps, or dressings to cover the skin after application; or applied to broken skin, rashes, or areas of skin irritation. These practices may increase the degree of systemic absorption and should be avoided. Consumers should consult their healthcare provider for instructions on safe use prior to applying topical anesthetics for medical or cosmetic purposes. Use a product with the lowest amount of anesthetic and apply the least amount possible to relieve pain. Some topical products are not recommended for use on otic or mucous membranes; specific product labeling should be consulted.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Safety and efficacy of topical patch have not been established in pediatric patients. Topical patches (both used and unused) may cause toxicities in children; used patches still contain large amounts of lidocaine; store and dispose patches out of the reach of children. Applying the topical patch to larger areas, for longer than recommended, or to broken or inflamed skin may result in increased absorption, high serum concentrations, and serious adverse effects; apply topical patch to intact skin only. Do not expose topical patch application site to external heat sources (eg, electric blankets, heating pads, heated water beds, heat lamps, tanning lamps, hot tubs, hot baths, saunas, sunbathing); although not evaluated, temperature-dependent increases in drug released from patch may occur. Topical patch may contain conducting metal (eg, aluminum) which may cause a burn to the skin during an MRI scan; remove topical patch prior to MRI; reapply patch after scan is completed. Due to the potential for altered electrical conductivity, remove topical patch before cardioversion or defibrillation.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Lidocaine cream (AneCream&reg;, L-M-X&reg; 4, L-M-X&reg; 5), lidocaine foam (Anestafoam&trade;), and lidocaine gel (Topicaine &reg;) contain benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; use lidocaine products containing benzyl alcohol with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites. Lidocaine cream (AneCream&reg;, L-M-X&reg; 4, L-M-X&reg; 5), lidocaine foam (Anestafoam&trade;), lidocaine gel (Burn Jel&reg;), and lidocaine topical patch (Lidoderm&reg;) contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; use dosage forms containing propylene glycol with caution in neonates. Some products contain bisulfites (consult specific product information) which may cause allergic reactions in susceptible individuals.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F8768676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2A6 (minor), CYP2B6 (minor), CYP2C9 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8768677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antiarrhythmic Agents (Class III): Lidocaine (Topical) may enhance the arrhythmogenic effect of Antiarrhythmic Agents (Class III). Antiarrhythmic Agents (Class III) may increase the serum concentration of Lidocaine (Topical). This mechanism specifically applies to amiodarone and dronedarone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the arrhythmogenic effect of Lidocaine (Topical). Disopyramide may increase the serum concentration of Lidocaine (Topical). Specifically, the unbound/free fraction of lidocaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8768628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8768629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies with systemic lidocaine have not shown teratogenic effects. Lidocaine and the MEGX metabolite cross the placenta. Topical lidocaine is used locally to provide analgesia prior to episiotomy and during repair of obstetric lacerations. Cumulative exposure from all routes of administration should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10529629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10529630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthetic effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Jelly: 3-5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Patch (5%): ~4 hours (Davies, 2004)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10529632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Extent and rate variable; dependent upon concentration, dose, application site, and duration of exposure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Topical patch (5%): 3% &plusmn; 2% is expected to be absorbed with recommended doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: 90% hepatic; active metabolites monoethylglycinexylidide (MEGX) and glycinexylidide (GX) can accumulate and may cause CNS toxicity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak serum concentration: Topical patch (5%): 11 hours (following application of 3 patches)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Urine (&lt;10% as unchanged drug)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10529685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/46/29413?source=see_link\">",
"      see \"Lidocaine (topical): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral (solution): Instruct patient to swish medication around mouth and then spit it out; if unable to spit, can apply with cotton tip to painful area.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical/cosmetic procedures: The FDA recommends checking with your healthcare provider prior to administration of product to ensure proper technique; may cause decreased sensation to pain, heat, or cold in the area and/or decreased muscle strength (depending on area of application) until effects wear off; use necessary caution to reduce incidence of possible injury until full sensation returns. Report irritation, pain, persistent numbness, tingling, or swelling; restlessness, dizziness, or acute weakness; blurred vision; ringing in ears; or respiratory difficulty to your healthcare provider.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical patch: Patch may be cut to appropriate size. Remove immediately if burning sensation occurs. Wash hands after application. Keep used and unused patches out of the reach of children; used patches still contain large amounts of lidocaine; fold used patch so adhesive side sticks to itself; dispose of used patch properly and out of the reach of children.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Davies PS and Galer BS, \"Review of Lidocaine Patch 5% Studies in the Treatment of Postherpetic Neuralgia,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 2004, 64(9):937-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?32/50/33574/abstract-text/15101784/pubmed\" id=\"15101784\" target=\"_blank\">",
"        15101784",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lehr VT, Cepeda E, Frattarelli DA, et al, \"Lidocaine 4% Cream Compared With Lidocaine 2.5% and Prilocaine 2.5% or Dorsal Penile Block for Circumcision,\"",
"      <i>",
"       Am J Perinatol",
"      </i>",
"      , 2005, 22(5):231-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?32/50/33574/abstract-text/16041631/pubmed\" id=\"16041631\" target=\"_blank\">",
"        16041631",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16015 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-77.94.48.4-442DE206A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33574=[""].join("\n");
var outline_f32_50_33574=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768584\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768585\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529567\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12675240\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529633\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768875\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768595\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529684\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529628\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529604\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768638\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529624\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529626\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529625\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768676\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768677\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768628\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768629\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529629\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529630\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529632\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529685\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16015\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16015|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/30/4579?source=related_link\">",
"      Lidocaine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/39/12915?source=related_link\">",
"      Lidocaine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=related_link\">",
"      Lidocaine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=related_link\">",
"      Lidocaine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=related_link\">",
"      Lidocaine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/11/20663?source=related_link\">",
"      Lidocaine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=related_link\">",
"      Lidocaine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/46/29413?source=related_link\">",
"      Lidocaine (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33575="Nasal trauma and fractures in children";
var content_f32_50_33575=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nasal trauma and fractures in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Donna Reyes Mendez, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Annie Lapointe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33575/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33575/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?32/50/33575/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the facial bones are uncommon occurrences in children younger than five years of age; the incidence increases with increasing age and peaks between 16 and 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/1\">",
"     1",
"    </a>",
"    ]. One reason for this difference is that young children are relatively protected from the mechanical forces that lead to facial injury [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/2\">",
"     2",
"    </a>",
"    ]. As they age, they participate in activities that increase the risk of exposure to such forces (eg, falls from height, sports, bicycle riding, etc).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nasal bones and mandible are the facial bones most commonly fractured in children [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/3\">",
"     3",
"    </a>",
"    ]. Nasal fractures occur more commonly than do mandibular fractures because they require less force to produce [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/4\">",
"     4",
"    </a>",
"    ]. Childhood nasal trauma typically results from falls, contact sports, weight lifting, and automobile crashes (usually involving bicyclists or pedestrians) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]. Child abuse also must be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of these injuries are minor. In one retrospective series of 241 children with nasal injury 98 of whom were examined by rhinoscopy, 73 cases involved septal deviation, subluxation, or fracture (30 percent), 13 cases septal hematoma formation (5 percent), and 12 cases subperichondrial abscess (5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The upper one-third of the nose is supported by the paired nasal bones and the frontal processes of the maxilla; the lower two-thirds are maintained by cartilaginous structures [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"     9",
"    </a>",
"    ]. The superior portion of the nasal bones is thick and relatively resistant to fracture. In contrast, the inferior portion is thin and weak. The bony nasal septum articulates with the undersurface of the nasal bones to provide support to the nasal dorsum. The lacrimal bones and ethmoid labyrinth lie deep to this bony pyramid [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A paired cartilaginous framework, separated in the midline by attachments to the quadrangular septal cartilage, provides support to the lower two-thirds of the nose. The upper lateral cartilages attach to the undersurface of the nasal bones and support the middle one-third. The lower lateral cartilages consist of medial and lateral crus, which join in the midline to form the tip of the nose and support the lower one-third [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rich blood supply of the nose, derived from the internal and external carotid arteries, accounts for the frequency and intensity of epistaxis and swelling in patients with nasal trauma. Kiesselbach plexus, the vascular watershed area of the anteroinferior nasal septum, is the site of origin of most nosebleeds (",
"    <a class=\"graphic graphic_figure graphicRef54180 \" href=\"UTD.htm?0/23/374\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct blows to the nose can fracture the nasal skeleton and lead to displacement or depression of the nasal bones or septum [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/10\">",
"     10",
"    </a>",
"    ]. Because the nasal pyramid is variably cartilaginous during childhood, and the midline suture is unfused, greenstick fractures are more common [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, trauma to the nasal septum can tear the blood vessels that are adjacent to the septal cartilage. Hematomas form when blood collects in the space between the cartilage and the overlying mucoperichondrium. Expansion of the hematoma separates the cartilage from the mucoperichondrium, obstructing blood flow to the nasal cartilage and causing pressure-induced avascular necrosis of the nasal cartilage. Septal perforation and irreversible damage result after three to four days of ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/12\">",
"     12",
"    </a>",
"    ]. The accumulated blood and necrotic tissue also form a nidus for infection with bacteria colonizing the nasal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Infection of a septal hematoma may induce rapid resorption of necrotic cartilage but is not necessarily a prerequisite for this process [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. The replacement of necrotic tissue by fibrous tissue, retraction of scar tissue, and loss of support to the lower nose may lead to facial deformity, including saddle nose (",
"    <a class=\"graphic graphic_picture graphicRef58919 \" href=\"UTD.htm?19/39/20082\">",
"     picture 1",
"    </a>",
"    ), displacement of the maxilla, retraction of the anterior nasal septum (columella), widening of the nasal base, and diminished size of the nasal cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Naso-orbito-ethmoid fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Naso-orbito-ethmoid fractures occur with high impact to the central midface and involve complete separation of the nasal bones and the medial walls of the orbits from the frontal bone and the infraorbital rim. The bones typically are fragmented and displaced posteriorly into the ethmoid region. The medial canthal tendons, which are attached to the medial walls of the orbits, are shifted laterally with the fracture segments, resulting in increased inner canthal distance (traumatic telecanthus) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9783?source=see_link&amp;anchor=H8#H8\">",
"     \"Orbital fractures\", section on 'Nasoethmoid fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations may provide important clues to the site of fracture:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All children with facial trauma should be assessed for associated injuries to the cervical spine, central nervous system, chest, orbits, and teeth [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link&amp;anchor=H3#H3\">",
"       \"Evaluation of cervical spine injuries in children and adolescents\", section on 'History'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with a history of change in visual acuity, diplopia, and sensory deficits should have prompt evaluation for neurologic or ophthalmologic trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link\">",
"       \"Minor head trauma in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with malocclusion should be evaluated for mandibular fractures and dental injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6615?source=see_link&amp;anchor=H8#H8\">",
"       \"Jaw fractures in children\", section on 'Clinical evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=see_link&amp;anchor=H5#H5\">",
"       \"Evaluation and management of dental injuries in children\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluation of nasal symptoms following nasal trauma includes assessment of nasal obstruction, nasal bleeding, pain, anosmia, and cosmetic deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11,21\">",
"     11,21",
"    </a>",
"    ]. Assessment of previous nasal function and nasal appearance should also be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11,21\">",
"     11,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The typical symptoms of nasal septal hematoma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abscess are progressive nasal obstruction (95 percent), persistent or worsening pain (50 percent), rhinorrhea (25 percent), and fever (25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/7,21\">",
"     7,21",
"    </a>",
"    ]. Fever and constitutional signs may or may not be present in children with nasal septal abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The examination of children with nasal trauma should include inspection of the nose and facial structures, palpation of the facial and nasal bones, and internal examination of the nose [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/13\">",
"     13",
"    </a>",
"    ]. Children with facial trauma usually are apprehensive, particularly soon after the injury, and the examination may be hampered by lack of cooperation because of anxiety or pain [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. The use of sedation or analgesia may facilitate the evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, nasal bleeding and swelling, which occur soon after trauma, can impair the evaluation. Applying local pressure or topical vasoconstricting agents (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/46/41696?source=see_link\">",
"     phenylephrine",
"    </a>",
"    nasal spray, two squirts to each nostril) or nasal packing may be necessary to improve the ability to assess the septum for hematoma or deviation [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pertinent physical examination findings upon inspection include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Periorbital ecchymoses in the absence of other orbital findings is suggestive of nasal fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      External nasal deformity, epistaxis, edema, and ecchymosis suggest septal injury [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/13,22\">",
"       13,22",
"      </a>",
"      ]. Nasal deformity may be obscured by swelling (",
"      <a class=\"graphic graphic_figure graphicRef60039 \" href=\"UTD.htm?27/22/28000\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A flattened, broad nose with increased inner canthal distance and vertical orbital displacement suggest a naso-orbito-ethmoid fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/23-27\">",
"       23-27",
"      </a>",
"      ]. The normal mean inner canthal distance is 16 mm at birth and increases to 25 to 27 mm in the mature female and male face, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/28\">",
"       28",
"      </a>",
"      ], although there is ethnic variation [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/29,30\">",
"       29,30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After inspection, the nasal bones should be palpated for tenderness, deformity, mobility, crepitus, or step off. Pertinent physical examination findings upon palpation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tenderness over the frontal sinus may indicate frontal sinus fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tenderness to palpation of the tip of the nose is suggestive of septal hematoma [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Malocclusion and instability of the palate is indicative of a midfacial LeFort fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tenderness and instability on palpation of the anterior nasal spine from beneath the upper lip may indicate significant septal trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The intranasal cavity should be evaluated using a nasal speculum and appropriate lighting in all children with nasal trauma because septal injury can occur in the absence of the external findings described above [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9,13,14,22\">",
"     9,13,14,22",
"    </a>",
"    ]. In addition, the signs and symptoms of nasal septal injury may evolve during the 24 to 72 hours after injury. Children with nasal trauma should have close follow-up and reexamination soon after the injury occurs (see below).",
"   </p>",
"   <p>",
"    The presence of clear fluid in the nasal cavity may indicate a cerebrospinal fluid (CSF) leak as the result of an associated skull fracture, usually through the cribriform plate. Fluid should be tested for beta-2 transferrin, which is present only in CSF, perilymph, and aqueous humor [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/31\">",
"     31",
"    </a>",
"    ]. Bedside tests that have been used to identify CSF, such a characteristic appearance when placed on filter paper (blood at the center, surrounded by a clear ring of CSF) and detection of glucose in the fluid, are unreliable.",
"   </p>",
"   <p>",
"    Mucosal laceration with bleeding is suggestive of underlying cartilaginous injury. The septum should be examined for fracture, displacement, laceration, discoloration, and abnormal swelling [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11,21\">",
"     11,21",
"    </a>",
"    ]. The nasal septum usually is between 2 and 4 mm thick [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings suggestive of septal hematoma include [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/14,22\">",
"     14,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Asymmetry of the septum with a blue or red discoloration",
"     </li>",
"     <li>",
"      Swelling of the nasal mucosa that obstructs the nasal passage",
"     </li>",
"     <li>",
"      The size of the mass does not change with the application of topical vasoconstricting agents",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nasal septal abscesses typically are larger and more painful than are uncomplicated septal hematomas; the overlying mucosa may be inflamed and have an inflammatory exudate.",
"   </p>",
"   <p>",
"    Apparent septal deviation may be explained by a previous septal deviation, or may be caused by a hematoma, or abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15,32\">",
"     15,32",
"    </a>",
"    ]. Thus, the area of the septum that appears to be deviated should be palpated with a cotton-tipped applicator to determine whether it is compressible. Immediate consultation with an otorhinolaryngologist is warranted for children who have compressible lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Radiographic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs are not helpful in the diagnosis of nasal fractures in children and should not be substituted for a complete external and internal examination [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11,13,21,33,34\">",
"     11,13,21,33,34",
"    </a>",
"    ]. The nasal bones of children are poorly visualized on plain radiography because they are not fused and are composed primarily of cartilage [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Computed tomography with axial and coronal images of the maxillofacial bones and the base of the skull should be performed to evaluate naso-orbito-ethmoid fractures in children who present with flattening of the nasal dorsum [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. This examination should be performed also in children who have findings indicative of frontal sinus fracture, LeFort fracture, or cerebrospinal fluid leak [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of nasal trauma in infants and children depends upon their age, the degree of nasal obstruction, and associated injuries. Septal deviations that cause nasal airway obstruction in newborn infants should be repaired urgently by a pediatric otolaryngologist because newborns are preferential nose breathers [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. Similarly, children with septal hematomas or abscesses warrant prompt pediatric otolaryngology consultation. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Hematoma and abscess'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children with nasal trauma should maintain upright posture to prevent the formation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    facilitate the resolution of edema and hematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. Tetanus prophylaxis may be indicated for children who have associated soft tissue injuries and dirty wounds (",
"    <a class=\"graphic graphic_table graphicRef61087 \" href=\"UTD.htm?7/52/8013\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7353?source=see_link\">",
"     \"Tetanus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who have no symptoms, minimal swelling, and no septal deviation or hematoma do not need specific follow-up. Patients with nasal fracture but no septal hematoma may be referred to the otorhinolaryngologist within three to five days. This brief delay in evaluation permits resolution of the edema, facilitating visualization of the nasal structures. In addition, if parents are instructed to bring a recent photograph of the child to the appointment, the otorhinolaryngologist can compare the nasal contours before and after the trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Deviation and fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deviation of the nasal septum that was noted on the initial evaluation can be reduced by the otorhinolaryngologist at the follow-up visit. The short delay in definitive treatment has little adverse effect on outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15,37-39\">",
"     15,37-39",
"    </a>",
"    ]. However, delay beyond seven days may render reduction of nasal fractures more difficult or cause permanent displacement because the active growth centers in the child's nasal bones promote rapid healing. The fractured elements become difficult to mobilize after 7 to 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/11,15,21\">",
"     11,15,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most nasal fractures in children can be managed with closed reduction. Fractures with splayed nasal bones and no impactions can be reduced with bilateral digital compression on the dorsum for 10 to 15 minutes. Nasal deviation to one side often can be reduced by digital compression on the side of the deviation. The end-point of reduction in children is difficult to appreciate because the cartilaginous elements neither move into place as readily as the ossified elements do in adults, nor do the elements \"snap\" into place [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. Use of intranasal instrumentation may be necessary if digital compression alone is not successful (",
"    <a class=\"graphic graphic_picture graphicRef74348 \" href=\"UTD.htm?23/31/24052\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef53351 \" href=\"UTD.htm?30/59/31670\">",
"     picture 3",
"    </a>",
"    ). Open reduction may need to be performed if significant dislocations are present, the injury is more than two weeks old, or closed and intranasal instrumentation fail [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hematoma and abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of septal hematoma and abscess should be carried out urgently by an otorhinolaryngologist. These lesions should be aspirated by needle to confirm the diagnosis of hematoma or abscess. Aspirated material should be sent for Gram stain and aerobic and anaerobic cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of septal hematomas involves drainage followed by plication of the mucoperichondrial flaps to the cartilaginous septum with a through-and-through chromic suture [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/40\">",
"     40",
"    </a>",
"    ]. Septal abscesses are treated with incision, drainage, and nasal packing.",
"   </p>",
"   <p>",
"    Children who undergo drainage of either septal hematoma or abscess should be treated with systemic antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"     15",
"    </a>",
"    ]. Antibiotics should be chosen to cover anaerobes, Staphylococcus aureus, Streptococcus pneumoniae, group A beta-hemolytic streptococcus, and Haemophilus influenzae [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/7,17,41,42\">",
"     7,17,41,42",
"    </a>",
"    ]. Treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    is recommended until the results of cultures and susceptibility studies are available [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children who have had nasal trauma complicated by septal hematoma should be examined periodically for evidence of cosmetic deformities for 12 to 18 months after the injury [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24711256\">",
"    <span class=\"h1\">",
"     RETURN TO PLAY",
"    </span>",
"    &nbsp;&mdash;&nbsp;After fracture reduction, the nasal bones remain mobile for approximately two weeks and can be depressed by force for up to six weeks. Thus, most otolaryngologists have children with nasal fractures refrain from all sports activities for two weeks and contact sports (eg, American football, lacrosse, or wrestling) for six weeks. Most athletes successfully return to their sport after a nasal fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood nasal fracture may be complicated by structural or cosmetic deformity. In one study, 57 children with nasal fractures who had reached nasal maturity were compared with 50 individuals without history of nasal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/45\">",
"     45",
"    </a>",
"    ]. Functional complaints and angulation occurred with equal frequency in both groups. However, deviations of the osseous and cartilaginous pyramid, humps and saddle formations, and deviations of the septum found more frequently in the fracture group.",
"   </p>",
"   <p>",
"    In addition to the cosmetic complications, nasal fractures may be complicated by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Septal abscess (described above) may cause intracranial infection caused by direct spread to the cavernous sinus [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lacrimal duct obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/48\">",
"       48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Maxillary hypoplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Toxic shock syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/50\">",
"       50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Naso-oral-fistula [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33575/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/4/41026?source=see_link\">",
"       \"Patient information: Nose fracture (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/24/34178?source=see_link\">",
"       \"Patient information: Skull and facial fractures (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1688397\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nasal trauma in children can fracture the nasal skeleton and lead to displacement or depression of the nasal bones or septum. Because the nasal pyramid is variably cartilaginous during childhood, and the midline suture is unfused, greenstick fractures are more common. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Trauma to the nasal septum can tear the blood vessels that are adjacent to the septal cartilage and cause a septal hematoma. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of nasal symptoms following nasal trauma includes assessment of nasal obstruction, nasal bleeding, pain, anosmia, and cosmetic deformity. Symptoms of nasal septal hematoma",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abscess consist of progressive nasal obstruction, persistent or worsening pain after trauma, rhinorrhea, and fever. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician should perform a complete external and internal examination of the nose with attention to signs of associated injuries, including cervical spine injury, cerebrospinal fluid leak, naso-orbito-ethmoid fractures, and LeFort fractures. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs are not helpful in the diagnosis of nasal fractures in children and should not be performed solely for this purpose. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with clinical findings that suggest cerebrospinal fluid leaks, LeFort fractures, or naso-orbito-ethmoid fractures warrant computed tomography with axial and coronal images of the maxillofacial bones and the base of the skull and urgent consultation with an otolaryngologist. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with nasal fractures that cause airway obstruction and all patients with a septal hematoma should have prompt evaluation and care by an otolaryngologist. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Hematoma and abscess'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nasal fractures with deviation of the nasal septum should be reduced by an otorhinolaryngologist within seven days. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Deviation and fracture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with nasal fractures should refrain from all sports activities for two weeks and from contact sports (eg, American football, lacrosse, or wrestling) for six weeks. (See",
"      <a class=\"local\" href=\"#H24711256\">",
"       'Return to play'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/1\">",
"      Azevedo AB, Trent RB, Ellis A. Population-based analysis of 10,766 hospitalizations for mandibular fractures in California, 1991 to 1993. J Trauma 1998; 45:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/2\">",
"      Thaller SR, Mabourakh S. Pediatric mandibular fractures. Ann Plast Surg 1991; 26:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/3\">",
"      Anderson PJ. Fractures of the facial skeleton in children. Injury 1995; 26:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/4\">",
"      Maniglia AJ, Kline SN. Maxillofacial trauma in the pediatric age group. Otolaryngol Clin North Am 1983; 16:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/5\">",
"      Perkins SW, Dayan SH, Sklarew EC, et al. The incidence of sports-related facial trauma in children. Ear Nose Throat J 2000; 79:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/6\">",
"      T&uuml;reg&uuml;n MC, Zins JE. Maxillofacial fractures in weightlifters: a report of two cases. J Oral Maxillofac Surg 1999; 57:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/7\">",
"      Canty PA, Berkowitz RG. Hematoma and abscess of the nasal septum in children. Arch Otolaryngol Head Neck Surg 1996; 122:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/8\">",
"      Bl&aacute;hov&aacute; O. Late results of nasal septum injury in children. Int J Pediatr Otorhinolaryngol 1985; 10:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/9\">",
"      Hester TO, Campbell JP. Diagnosis and management of nasal trauma for primary care physicians. J Ky Med Assoc 1997; 95:386.",
"     </a>",
"    </li>",
"    <li>",
"     Elden LM, Potsic WP. Otolaryngology trauma. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1663.",
"    </li>",
"    <li>",
"     Bluestone CD, Stool SE, Kenna MA. Injuries of the nose, facial bones, and paranasal sinuses. In: Pediatric Otolaryngology, WB Saunders, Philadelphia 1996. p.880.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/12\">",
"      Wilson SW, Milward TM. Delayed diagnosis of septal haematoma and consequent nasal deformity. Injury 1994; 25:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/13\">",
"      Olsen KD, Carpenter RJ 3rd, Kern EB. Nasal septal injury in children. Diagnosis and management. Arch Otolaryngol 1980; 106:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/14\">",
"      Ginsburg CM, Leach JL. Infected nasal septal hematoma. Pediatr Infect Dis J 1995; 14:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/15\">",
"      Stucker FJ Jr, Bryarly RC, Shockley WW. Management of nasal trauma in children. Arch Otolaryngol 1984; 110:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/16\">",
"      Grymer LF, Bosch C. The nasal septum and the development of the midface. A longitudinal study of a pair of monozygotic twins. Rhinology 1997; 35:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/17\">",
"      Jalaludin MA. Nasal septal abscess--retrospective analysis of 14 cases from University Hospital, Kuala Lumpur. Singapore Med J 1993; 34:435.",
"     </a>",
"    </li>",
"    <li>",
"     Neuman MI, Eriksson E. Facial trauma. In: Textbook of Pediatric Emergency Medicine, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1475.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/19\">",
"      Mathog RH, Bauer W. Posttraumatic pseudohypertelorism. (Telecanthus). Arch Otolaryngol 1979; 105:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/20\">",
"      Holt GR, Holt JE. Incidence of eye injuries in facial fractures: an analysis of 727 cases. Otolaryngol Head Neck Surg 1983; 91:276.",
"     </a>",
"    </li>",
"    <li>",
"     Cummings CW, Fredrickson JM, Harker LA, et al. Nasal fractures. In: Otolaryngology Head &amp; Neck Surgery, Mosby, St. Louis 1998. p.866.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/22\">",
"      Lopez MA, Liu JH, Hartley BE, Myer CM. Septal hematoma and abscess after nasal trauma. Clin Pediatr (Phila) 2000; 39:609.",
"     </a>",
"    </li>",
"    <li>",
"     Manson PN. Skull and midface injuries. In: Plastic Surgery in Infancy and Childhood, Mustarde J, Jackson IT (Eds), Churchill Livingstone, Edinburgh 1988. p.145.",
"    </li>",
"    <li>",
"     Dufresne CR, Manson PN. Pediatric facial trauma. In: Plastic Surgery, McCarthy JG (Ed), WB Saunders, Philadelphia 1988. p.1142.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/25\">",
"      Crockett DM, Mungo RP, Thompson RE. Maxillofacial trauma. Pediatr Clin North Am 1989; 36:1471.",
"     </a>",
"    </li>",
"    <li>",
"     Converse JM, Dingamen RO. Facial injuries in children. In: Reconstructive Plastic Surgery, Converse JM (Ed), WB Saunders, Philadelphia 1977. p.1001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/27\">",
"      Cruse CW, Blevins PK, Luce EA. Naso-ethmoid-orbital fractures. J Trauma 1980; 20:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/28\">",
"      Pryor HB. Objective measurement of interpupillary distance. Pediatrics 1969; 44:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/29\">",
"      Wu KH, Tsai FJ, Li TC, et al. Normal values of inner canthal distance, interpupillary distance and palpebral fissure length in normal Chinese children in Taiwan. Acta Paediatr Taiwan 2000; 41:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/30\">",
"      Pivnick EK, Rivas ML, Tolley EA, et al. Interpupillary distance in a normal black population. Clin Genet 1999; 55:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/31\">",
"      Schlosser RJ, Bolger WE. Nasal cerebrospinal fluid leaks: critical review and surgical considerations. Laryngoscope 2004; 114:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/32\">",
"      Illum P. Long-term results after treatment of nasal fractures. J Laryngol Otol 1986; 100:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/33\">",
"      Li S, Papsin B, Brown DH. Value of nasal radiographs in nasal trauma management. J Otolaryngol 1996; 25:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/34\">",
"      Nigam A, Goni A, Benjamin A, Dasgupta AR. The value of radiographs in the management of the fractured nose. Arch Emerg Med 1993; 10:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/35\">",
"      Koltai PJ, Rabkin D. Management of facial trauma in children. Pediatr Clin North Am 1996; 43:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/36\">",
"      Remmler D, Denny A, Gosain A, Subichin S. Role of three-dimensional computed tomography in the assessment of nasoorbitoethmoidal fractures. Ann Plast Surg 2000; 44:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/37\">",
"      East CA, O'Donaghue G. Acute nasal trauma in children. J Pediatr Surg 1987; 22:308.",
"     </a>",
"    </li>",
"    <li>",
"     Handler SD. Maxillo-facial injuries. In: Facial Trauma, Torg J (Ed), Lea &amp; Febiger, Philadelphia 1990. p.78.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/39\">",
"      Olsen KD, Carpenter RJ 3rd, Kern EB. Nasal septal trauma in children. Pediatrics 1979; 64:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/40\">",
"      Stucker FJ Jr. Management of the scoliotic nose. Laryngoscope 1982; 92:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/41\">",
"      Brook I. Recovery of anaerobic bacteria from a post-traumatic nasal septal abscess. A report of two cases. Ann Otol Rhinol Laryngol 1998; 107:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/42\">",
"      Chundu KR, Naqvi SH. Nasal septal abscess caused by Haemophilus influenzae type B. Pediatr Infect Dis 1986; 5:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/43\">",
"      Ginsburg CM. Nasal septal hematoma. Pediatr Rev 1998; 19:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/44\">",
"      Cannon CR, Cannon R, Young K, et al. Characteristics of nasal injuries incurred during sports activities: analysis of 91 patients. Ear Nose Throat J 2011; 90:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/45\">",
"      Grymer LF, Gutierrez C, Stoksted P. Nasal fractures in children: influence on the development of the nose. J Laryngol Otol 1985; 99:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/46\">",
"      Eavey RD, Malekzakeh M, Wright HT Jr. Bacterial meningitis secondary to abscess of the nasal septum. Pediatrics 1977; 60:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/47\">",
"      Thomson CJ, Berkowitz RG. Extradural frontal abscess complicating nasal septal abscess in a child. Int J Pediatr Otorhinolaryngol 1998; 45:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/48\">",
"      Glatt HJ. Evaluation of lacrimal obstruction secondary to facial fractures using computed tomography or computed tomographic dacryocystography. Ophthal Plast Reconstr Surg 1996; 12:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/49\">",
"      Ousterhout DK, Vargervik K. Maxillary hypoplasia secondary to midfacial trauma in childhood. Plast Reconstr Surg 1987; 80:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/50\">",
"      Keller JL, Evan KE, Wetmore RF. Toxic shock syndrome after closed reduction of a nasal fracture. Otolaryngol Head Neck Surg 1999; 120:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33575/abstract/51\">",
"      Cuddihy PJ, Srinivasan V. An unusual presentation of a nasal septal abscess. J Laryngol Otol 1998; 112:775.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6558 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.80.101-607E99995B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33575=[""].join("\n");
var outline_f32_50_33575=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1688397\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Naso-orbito-ethmoid fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Radiographic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Deviation and fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hematoma and abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24711256\">",
"      RETURN TO PLAY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1688397\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6558\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6558|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/23/374\" title=\"figure 1\">",
"      Anatomy medial nasal wall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/22/28000\" title=\"figure 2\">",
"      Nasal fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6558|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/39/20082\" title=\"picture 1\">",
"      Saddle nose deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/31/24052\" title=\"picture 2\">",
"      Instruments closed reduction nasal fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/59/31670\" title=\"picture 3\">",
"      Closed reduction of a nasal fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6558|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/52/8013\" title=\"table 1\">",
"      Tetanus prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=related_link\">",
"      Evaluation and management of dental injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6615?source=related_link\">",
"      Jaw fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=related_link\">",
"      Minor head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9783?source=related_link\">",
"      Orbital fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/4/41026?source=related_link\">",
"      Patient information: Nose fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/24/34178?source=related_link\">",
"      Patient information: Skull and facial fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7353?source=related_link\">",
"      Tetanus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33576="Treatment of delayed gastric emptying";
var content_f32_50_33576=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of delayed gastric emptying",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Michael Camilleri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33576/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?32/50/33576/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed gastric emptying (also referred to as gastric stasis and gastroparesis) may be manifested clinically by a variety of symptoms including nausea, vomiting, early or easy satiety, bloating, and weight loss. The management of this problem has four components:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Supportive measures (eg, hydration and nutrition)",
"     </li>",
"     <li>",
"      Optimizing glycemic control in patients with diabetes mellitus",
"     </li>",
"     <li>",
"      Medications",
"     </li>",
"     <li>",
"      Occasional surgical therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will discuss these treatment measures. The pathophysiology, etiology, and diagnosis of gastric stasis are discussed separately and in a guideline issued by the American Gastroenterological Association. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14312?source=see_link\">",
"     \"Pathogenesis of delayed gastric emptying\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"     \"Etiology and diagnosis of delayed gastric emptying\"",
"    </a>",
"    .) The American Gastroenterological Association (AGA) technical review for gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/1\">",
"     1",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     file://www.gastro.org/practice/medical-position-statements",
"    </a>",
"    . The result on a gastric emptying study, the state of nutrition of the patient, and the ability to tolerate food are practical guides to the management of patients (",
"    <a class=\"graphic graphic_algorithm graphicRef79991 \" href=\"UTD.htm?29/29/30161\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Issues specific to patients who develop gastroparesis in the setting of malignant disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7226?source=see_link\">",
"     \"Malignancy-associated gastroparesis: Pathophysiology and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIETARY MODIFICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some dietary modifications are appropriate in patients in whom delayed gastric emptying has been demonstrated, but the expected clinical benefit is often modest. Fat delays emptying and nondigestible fiber (eg, fresh fruits and vegetables) may be poorly emptied since they require effective interdigestive antral motility that is frequently absent in patients with significant gastric emptying disorders such as diabetic and post-vagotomy gastroparesis. Thus, patients should be advised to consume a low-fat diet (without nondigestible fiber) and frequent, small meals. Assistance and education from a dietitian is helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/2\">",
"     2",
"    </a>",
"    ]. In more severe cases, substitution of mixed meals with homogenized or liquid meals supplemented with vitamins may be helpful. Enteral nutrition via a jejunostomy tube may occasionally be required, while parenteral nutrition should be restricted to patients with severe gastric and small intestine dysmotility in whom enteral feeding becomes impossible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hydration and nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recurrent vomiting and reduced oral intake associated with delayed gastric emptying may result in hypokalemia, metabolic alkalosis, dehydration, and deterioration in the control of diabetes mellitus. Patients with gastric stasis syndromes also develop essential element and mineral and vitamin deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/3\">",
"     3",
"    </a>",
"    ]. Those who have had previous gastric surgery are particularly susceptible to deficiencies of iron (because of failure to reduce dietary divalent iron to the more easily absorbable ferric or trivalent form) and vitamin B12 (because of the lack of intrinsic factor); the extent of resection determines the severity of these deficiencies.",
"   </p>",
"   <p>",
"    Supplementation of fluids, electrolytes, and nutrients should be achieved by the simplest, least invasive method that is effective for the individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/4\">",
"     4",
"    </a>",
"    ]. Oral supplementation may be effective in some, since liquids typically empty from the stomach more easily than solids, and liquid emptying is often normal even when solid emptying is markedly delayed. Liquidized or homogenized meals and liquid supplements (eg, homogenized protein supplements dissolved in skimmed milk) with liquid vitamin supplements provide a means to deliver calories, proteins, minerals, and vitamins. As noted above, high fat and fiber diets should be avoided since the former delays gastric emptying and the latter requires preservation of the interdigestive antral migrating motor complex for emptying. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14312?source=see_link\">",
"     \"Pathogenesis of delayed gastric emptying\"",
"    </a>",
"    .) Administration of an antiemetic by suppository or parenteral route may facilitate oral feeding in selected cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Jejunal feeding tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;If oral supplementation is unsuccessful and gastric stasis is due to a disorder of gastric motor function, a jejunal feeding tube can be placed percutaneously (percutaneous endoscopic jejunostomy) or by laparoscopy or mini-laparotomy depending upon the available expertise. The feeding tube provides a means to deliver liquid nutrients beyond the stomach at rates that allow the majority of calories and nutrients to be delivered by continuous infusion at night. These patients are permitted small volume liquid meals by mouth during the day. It is customary to try nasojejunal feeding for three days to insure that at least 80 mL of nutrient can be delivered per hour, since this rate is essential if jejunal feeding is to succeed in the long term.",
"   </p>",
"   <p>",
"    The selection of the nutrient formula should be discussed with an expert in nutrition, and in general, is guided by the individual patient's caloric, fat, protein, and supplement needs. Other considerations include the caloric density and osmolality of the formula, and the concomitant presence of small intestinal disease, which may reduce the tolerance to high osmolality and high nitrogen-containing formula. In general, there appear to be no significant advantages to using elemental diets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Parenteral nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral nutrition is seldom necessary in patients with gastric stasis unless it is part of a generalized motility disorder. Patients with severe dilatation or diffuse myopathic processes (eg, hollow visceral myopathy, progressive systemic sclerosis) may fail other methods of nutritional support and pharmacotherapy. Parenteral nutrition restores a normal nutritional state in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/35/41529?source=see_link\">",
"     \"Gastrointestinal manifestations of systemic sclerosis (scleroderma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GLYCEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetes mellitus is a common cause of delayed gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\"",
"    </a>",
"    .) It has been proposed, but not proven, that better glycemic control would improve gastric motor function. This hypothesis is based in part upon the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The induction of hyperglycemia in healthy controls results in antral hypomotility, stimulates isolated pyloric pressure waves, and increases the compliance of the gastric fundus, all of which retard gastric emptying [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acute hyperglycemia can also affect gastric myoelectrical activity and slow gastric emptying in patients with diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Furthermore, hyperglycemia appears to attenuate the efficacy of prokinetic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the role of chronic hyperglycemia is less clear. In one large review, for example, there was no significant difference in gastric emptying rates in those with blood glucose values above or below 270",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (15",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another potential concern is that glycemic control may be decreased in patients who have delayed gastric emptying (particularly in those receiving insulin), even if asymptomatic. Two factors may contribute to this problem: variability in glucose absorption in patients treated with intensive insulin regimens; and impaired absorption of oral hypoglycemic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/15\">",
"     15",
"    </a>",
"    ]. However, there are no conclusive data showing that treatment of gastric stasis improves long-term diabetic control or prevents complications.",
"   </p>",
"   <p>",
"    An important consideration is that incretin-based therapies such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/22/13669?source=see_link\">",
"     pramlintide",
"    </a>",
"    and GLP1 analogues (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14375?source=see_link\">",
"     exenatide",
"    </a>",
"    ) retard gastric emptying. Thus, iatrogenic gastroparesis should be considered and medications for glycemic control modified before instituting treatment for gastroparesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both prokinetic and antiemetic agents may be useful in the treatment of delayed gastric emptying. Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    is the treatment of choice for patients who cannot take oral medications. While cisapride used to be the drug of choice for those who can ingest oral liquids, its availability is severely restricted in the United States. Alternative oral prokinetics are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     domperidone",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Macrolide antibiotics",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H128227567\">",
"    <span class=\"h3\">",
"     Erythromycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    (erythromycin lactobionate, 3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every eight hours) may be used to \"restart\" or \"kick-start\" the stomach during acute episodes of gastric stasis in which oral intake is not tolerated. Infusion should be performed over 45 minutes to avoid damaging peripheral veins and to increase patient comfort. Erythromycin induces high amplitude gastric propulsive contractions that literally dump solid residue, including nondigestible materials, out of the stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Erythromycin also stimulates fundic contractility, or at least inhibits the accommodation response of the proximal stomach after food ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An illustrative report included 10 patients with diabetic gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/19\">",
"     19",
"    </a>",
"    ]. The intravenous administration of 250 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    normalized the prolonged gastric emptying times for both solids and liquids. Gastric retention 120 minutes after a solid meal was reduced from 63 percent with placebo to 4 percent with erythromycin; corresponding values after a liquid meal were 32 and 4 percent. A lesser though significant improvement was noted after four weeks of oral erythromycin (250 mg three times daily).",
"   </p>",
"   <p>",
"    Evidence supporting a benefit of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    is generally weak. A systematic review identified 35 clinical trials involving erythromycin for gastroparesis of which five fulfilled inclusion criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/20\">",
"     20",
"    </a>",
"    ]. All studies were small (&le;13 subjects), of short duration (&le;4 weeks) and had methodologic weaknesses. Nevertheless, improvement was reported in 26 of 60 patients (43 percent).",
"   </p>",
"   <p>",
"    Potential side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    remain a concern, including gastrointestinal toxicity, ototoxicity, pseudomembranous colitis, the induction of resistant bacterial strains, and the risk of sudden death due to long QT syndrome, particularly when used in patients taking medications that inhibit CYP3A4 (",
"    <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .) Thus, the",
"    <strong>",
"     chronic",
"    </strong>",
"    administration of erythromycin should be restricted to patients who are resistant to other medications and who demonstrate improvement in symptoms and tolerance of oral feeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H128227574\">",
"    <span class=\"h3\">",
"     Azithromycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     Azithromycin",
"    </a>",
"    has been used as an alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    . Azithromycin lacks the significant drug-drug interactions seen with erythromycin that have been related to QT prolongation and sudden cardiac death, though it is a weak inhibitor of CYP3A4, so QT prolongation with some drugs may occur. Arguments the use of azithromycin include its higher cost relative to erythromycin and potential antibiotic resistance.",
"   </p>",
"   <p>",
"    Data on the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    for the treatment of delayed gastric emptying are limited:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective case-control study with 120 patients, the mean half-time of gastric emptying did not differ between patients who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      and those who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      (10 versus 12 minutes) [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A manometric study found that when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      were given in similar doses intravenously, they had a similar positive effect on antral motility [",
"      <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/22\">",
"       22",
"      </a>",
"      ]. When a higher dose of azithromycin was used (500 mg), the mean amplitude, duration of antral activity, and motility index were all increased compared with erythromycin (250 mg).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cisapride",
"    </span>",
"    &nbsp;&mdash;&nbsp;The availability of cisapride has been severely restricted in the US, although it remains available in several other countries. Cisapride has been associated with important drug interactions (that have caused cardiac arrhythmias and death) with medications that are metabolized by the cytochrome P450-3A4 isoenzyme (eg, macrolide antibiotics, antifungals, and phenothiazines). In the United States, prescriptions for the drug can only be filled directly through the manufacturer after providing documentation as to need for the drug and assessment of risk factors for cardiac arrhythmias in the individual patient (eg, a QTc &gt;0.45 seconds). This complication is generally observed only when cisapride is used at excessive doses, or when a concomitant drug inhibits the metabolism of cisapride (",
"    <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"     table 1",
"    </a>",
"    ). In general, this has not been observed in adults when the dose was &lt;1",
"    <span class=\"nowrap\">",
"     mg/kg/day.",
"    </span>",
"   </p>",
"   <p>",
"    Cisapride",
"    stimulates 5HT4 receptors, resulting in release of acetylcholine from the neurons in the myenteric plexus [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/23\">",
"     23",
"    </a>",
"    ]. It stimulates antral and duodenal motility and may improve antroduodenal coordination in healthy subjects and in diabetics with autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cisapride accelerates gastric emptying of solids and liquids in a variety of gastric stasis syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]; this effect has been maintained during long-term (one year) open trials [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Cisapride may be more potent and better tolerated than equivalent doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cisapride can be introduced once the patient can tolerate oral liquids at a dose of 10 to 20 mg four times daily, one-half hour before each meal and at bedtime. Side effects include abdominal discomfort and increased frequency of bowel movements; both tend to be reduced by adjustment of the dose. In addition, the total dose of cisapride should not exceed 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in adults (60 to 80 mg is maximal). There is no evidence of increasing benefit with higher doses. Cisapride is only available through a special IND program since it has been associated with cardiac dysrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Metoclopramide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    is an alternative to intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    for patients who cannot take oral medications [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/29\">",
"     29",
"    </a>",
"    ]. Metoclopramide has both antiemetic and some prokinetic activity. However, oral metoclopramide has the potential for central side effects (anxiety, restlessness, depression) and hyperprolactinemia. It is generally less well-tolerated than cisapride [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/26\">",
"     26",
"    </a>",
"    ]. Extrapyramidal side effects and the risk of tardive dyskinesia, although rare, have led to a Black Box warning. A 2010 literature review noted that evidence from large, national prescription databases in the United Kingdom and Sweden recorded a far lower incidence of tardive dyskinesia (less than one percent) than was suggested from the case series that were typically collected at tertiary referral clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/30\">",
"     30",
"    </a>",
"    ]. Physicians should document the discussion of potential adverse effects of metoclopramide in the medical record when they prescribe metoclopramide.",
"   </p>",
"   <p>",
"    Given the impact of gastroparesis on morbidity, hospitalizations and mortality, it may be necessary to consider the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    , which should be exclusively for gastroparesis not responding to other treatments, and not for reflux disease, or emesis for which there are more effective and safer medications [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lowest effective dose for the individual patient should be sought. A liquid formulation may allow for improved effectiveness with lower dosing since it may empty better from the stomach. In addition, liquid formulation also allows for easier dose titration. Treatment should be started with a test dose (eg, 5 mg, 15 minutes before meals and at bedtime), titrating to identify lowest efficacious dose. \"Drug holidays\" or dose reductions (eg, 5 mg, before two main meals of the day) should be implemented whenever clinically possible. The patient should be warned to inform the physician when any involuntary movement occurs; tardive dyskinesia may be reversible and early recognition followed by discontinuation may lead to its resolution [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/30\">",
"     30",
"    </a>",
"    ]. Many patients can tolerate treatment with up to 40 mg of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    per day (in divided doses) without significant adverse effects.",
"   </p>",
"   <p>",
"    Some advocate the use of subcutaneous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    at a dose of 5 to 10 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/29\">",
"     29",
"    </a>",
"    ]. Experience with this route of administration is limited. Subcutaneous administration should be avoided in patients with a known predisposition to side effects from metoclopramide. We suggest that a test dose of 2 mg subcutaneously should be tried first if the parenteral route is to be used at all.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Domperidone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     Domperidone",
"    </a>",
"    is not approved for use by the Food and Drug Administration (FDA) in the United States but is available in Canada and other countries. However, the FDA has encouraged \"physicians who would like to prescribe domperidone for their patients with severe gastrointestinal disorders that are refractory to standard therapy to open an Investigational New Drug Application.\" The FDA domperidone investigational new drug section can be contacted at DomperidoneIND@fda.hhs.gov.",
"   </p>",
"   <p>",
"    Studies of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     domperidone",
"    </a>",
"    for treatment of gastroparesis have generally been small and had important methodologic limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/33\">",
"     33",
"    </a>",
"    ]. Nevertheless, efficacy of domperidone in diabetic gastroparesis is probably similar to that of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Animal studies suggest that, like cisapride, domperidone may increase the risk of cardiac arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antiemetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiemetics have been used liberally in the past together with prokinetic agents including cisapride to provide symptom relief. However, more recent recommendations have cautioned against the concomitant use of phenothiazines and cisapride (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Cisapride'",
"    </a>",
"    above). Antihistamines (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ) can be given orally or rectally, and phenothiazines (eg, compazine) parenterally or rectally according to clinical indications. The 5HT3 antagonists such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/2/21544?source=see_link\">",
"     ondansetron",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32550?source=see_link\">",
"     granisetron",
"    </a>",
"    , or tropisetron, confer no advantage over other antiemetics in patients with gastric stasis syndromes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Botulinum toxin injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pilot observational studies suggested that injection of botulinum toxin into the pylorus can improve gastric emptying and symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/37-41\">",
"     37-41",
"    </a>",
"    ]. A controlled trial involving 32 patients found no significant difference in gastric emptying or symptoms compared with placebo at one month [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/42\">",
"     42",
"    </a>",
"    ]. There were no serious side effects. A single, randomized controlled crossover trial of 23 patients with predominantly idiopathic gastroparesis also showed no significant benefit of botulinum toxin over saline placebo in improving either symptoms or the rate of gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/43\">",
"     43",
"    </a>",
"    ]. Thus, larger, controlled trials are needed before this therapy can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DECOMPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneously or laparoscopically placed gastrostomy or jejunostomy tubes decompress the dilated upper gut; in patients with more generalized motility disorders, this reduces the need of hospitalization for acute exacerbations of dysmotility by a factor of five [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. In one report, for example, hospital readmissions in 12 patients with chronic intestinal pseudoobstruction decreased from 0.5 to 0.1 per year after placement of an enterostomy tube [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients without permanent enterostomy tubes, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    usually relieves acute gastric stasis rapidly. Thus, nasogastric decompression is rarely necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is",
"    <strong>",
"     rarely",
"    </strong>",
"    indicated in patients with nonobstructive gastric stasis, except for the provision of effective decompression (venting gastrostomy or jejunostomy), or for completion or subtotal gastrectomy in patients with a previous partial gastrectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/46\">",
"     46",
"    </a>",
"    ]. In one study, for example, 40 patients who presented with severe chronic gastric atony (32 postvagotomy, 6 idiopathic, and 2 with diabetic gastroparesis) underwent either extensive subtotal or near total gastrectomy and Roux-en-Y gastrojejunostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/47\">",
"     47",
"    </a>",
"    ]. The outcome was assessed in terms of symptoms improving and Visick grade:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade 1 is a perfect result, an asymptomatic patient",
"     </li>",
"     <li>",
"      Grade 2 refers to mild, intermittent symptoms that are easily controlled by diet",
"     </li>",
"     <li>",
"      Grade 3 refers to moderate symptoms without substantial interference with lifestyle",
"     </li>",
"     <li>",
"      Grade 4 represents an unsatisfactory outcome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among the 39 patients followed for a mean of 32 months, 31 patients (79 percent) had fewer symptoms postoperatively; 26 patients (66 percent) improved at least one Visick grade postoperatively and 22 patients (56 percent) improved from grades 3 and 4 preoperatively to grades 1 and 2 postoperatively. One-third showed no improvement. There were no postoperative deaths. Surgery was recommended for patients with intractable nausea, vomiting, or malnutrition.",
"   </p>",
"   <p>",
"    Another report included 62 patients who underwent completion gastrectomy for severe postgastrectomy gastric stasis [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/48\">",
"     48",
"    </a>",
"    ]. Surgery was considered successful (Visick grades I or II) in 43 percent of patients after a mean follow-up of five years. Univariate analysis revealed no preoperative characteristics that predicted a good outcome. In contrast, a poor outcome was predicted by the combination of nausea, need for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    , and retained food in the stomach on endoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Roux-en-Y stasis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with postgastrectomy gastric stasis experience significant postoperative difficulties, including nausea, vomiting, early satiation, and the Roux-en-Y stasis syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/49\">",
"     49",
"    </a>",
"    ]. Stasis occurs in the gastric remnant in this disorder, as well as in the distal efferent jejunal Roux limb [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/50\">",
"     50",
"    </a>",
"    ]. The syndrome is caused in part by a motility disorder of the Roux limb [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/51\">",
"     51",
"    </a>",
"    ]. Transection of the jejunum separates the limb from the natural small intestinal pacemaker (located in the duodenum). Ectopic pacemakers in the limb trigger retrograde contractions in its proximal portion. Surgical variations (such as the \"uncut\" Roux limb) may help prevent this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33576/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This syndrome is particularly difficult to manage. It is important to ensure that the Roux limb is not longer than 45 cm, since greater length is associated with local stasis. Some patients who have retained food predominantly in the gastric remnant improve after subtotal gastrectomy, retaining only a cuff of proximal stomach anastomosed to the Roux limb. Otherwise, Roux-en-Y stasis is treated the same way as chronic intestinal pseudo-obstruction, with emphasis on hydration, antiemetics and prokinetic agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=see_link\">",
"     \"Chronic intestinal pseudo-obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     GASTRIC ELECTRICAL STIMULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric electrical stimulation remains a treatment for which there is limited controlled trial evidence of efficacy. It is designated as a humanitarian use device for refractory diabetic and idiopathic gastroparesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31574?source=see_link\">",
"     \"Electrical stimulation for gastroparesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/60/8130?source=see_link\">",
"       \"Patient information: Gastroparesis (delayed gastric emptying) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delayed gastric emptying may be manifested clinically by a variety of symptoms including nausea, vomiting, early or easy satiety, bloating, upper abdominal pain, and weight loss. The management of this problem consists of providing supportive measures (eg, hydration and nutrition), optimizing glycemic control in patients with diabetes mellitus, medical therapy, and occasional surgical therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acute exacerbations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For acute exacerbations of delayed gastric emptying we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      (erythromycin lactobionate 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously) every eight hours (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ), although it is effective in only about 40 percent of patients. An alternative is to use subcutaneous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       metoclopramide",
"      </a>",
"      (5 to 10 mg three times daily) after a test dose to exclude extrapyramidal adverse effects (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Metoclopramide'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Chronic or subacute",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some dietary modifications are appropriate in patients in whom delayed gastric emptying has been demonstrated, but the expected clinical benefit is often modest. We suggest that patients consume a low-fat diet (without nondigestible fiber) and frequent, small meals (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In more severe cases, substitution of mixed meals with homogenized or liquid meals supplemented with vitamins may be helpful. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Dietary modifications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest cisapride for subacute or chronic delay in gastric emptying in countries in which it remains available (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Several precautions must be taken and the maximum dose should be kept below 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      or 60 mg per day in adults. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cisapride'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In settings where cisapride is not available, we suggest either subcutaneous or oral (tablet, oral dissolvable or liquid formulation)",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       metoclopramide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"       domperidone",
"      </a>",
"      (40 to 80 mg orally per day in four divided doses in countries where it is approved) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      (125 to 250 mg orally three times daily) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In patients with the more severe gastroparesis, the liquid formulations are likely to provide more consistent effects. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Metoclopramide'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Domperidone'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Potential side effects of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      include gastrointestinal toxicity, ototoxicity, pseudomembranous colitis, the induction of resistant bacterial strains, and the risk of sudden death due to long QT syndrome, particularly when used in patients taking medications that inhibit CYP3A4 (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"       table 1",
"      </a>",
"      ). Because of these side effects, some are now using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      instead of erythromycin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"       \"Acquired long QT syndrome\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H128227567\">",
"       'Erythromycin'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H128227574\">",
"       'Azithromycin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk of adverse effects from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       metoclopramide",
"      </a>",
"      can be reduced if the dose is kept at or below 40 mg per day but the drug has been given a black box warning because of the risk of extrapyramidal side-effects, which can be permanent. All these prokinetics should be administered 10 to 15 minutes before meals; an additional dose before bedtime might be useful.",
"     </li>",
"     <li>",
"      The decision to place a tube in the stomach is determined by the need to decompress to relieve pain and nausea. We suggest jejunal feeding tubes when there is a need for enteral nutrition such as in patients who cannot maintain their nutritional status or adequate hydration orally (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Decompression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest gastric electrical stimulation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ) on a humanitarian basis or parenteral nutrition for intractable symptoms unresponsive to the above remedies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31574?source=see_link\">",
"       \"Electrical stimulation for gastroparesis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/1\">",
"      Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/2\">",
"      Parkman HP, Yates KP, Hasler WL, et al. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology 2011; 141:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/3\">",
"      Ogorek CP, Davidson L, Fisher RS, Krevsky B. Idiopathic gastroparesis is associated with a multiplicity of severe dietary deficiencies. Am J Gastroenterol 1991; 86:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/4\">",
"      Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol 1994; 89:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/5\">",
"      Warner E, Jeejeebhoy KN. Successful management of chronic intestinal pseudo-obstruction with home parenteral nutrition. JPEN J Parenter Enteral Nutr 1985; 9:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/6\">",
"      Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/7\">",
"      Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991; 32:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/8\">",
"      Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/9\">",
"      Jebbink RJ, Samsom M, Bruijs PP, et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology 1994; 107:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/10\">",
"      Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/11\">",
"      Jones KL, Berry M, Kong MF, et al. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999; 22:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/12\">",
"      Petrakis IE, Kogerakis N, Prokopakis G, et al. Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects. Dig Dis Sci 2002; 47:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/13\">",
"      Petrakis IE, Kogerakis N, Vrachassotakis N, et al. Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects. Abdom Imaging 2002; 27:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/14\">",
"      Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/15\">",
"      Groop LC, Luzi L, DeFronzo RA, Melander A. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 1989; 2:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/16\">",
"      Prather CM, Camilleri M, Thomforde GM, et al. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol 1993; 264:G928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/17\">",
"      Keshavarzian A, Isaac RM. Erythromycin accelerates gastric emptying of indigestible solids and transpyloric migration of the tip of an enteral feeding tube in fasting and fed states. Am J Gastroenterol 1993; 88:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/18\">",
"      Bruley des Varannes S, Parys V, Ropert A, et al. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 1995; 109:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/19\">",
"      Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990; 322:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/20\">",
"      Maganti K, Onyemere K, Jones MP. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003; 98:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/21\">",
"      Larson JM, Tavakkoli A, Drane WE, et al. Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. J Neurogastroenterol Motil 2010; 16:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/22\">",
"      Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2010; 55:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/23\">",
"      Schuurkes J. Effect of cisapride on gastric motility. Z Gastroenterol 1990; 28 Suppl 1:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/24\">",
"      Wehrmann T, Lembcke B, Caspary WF. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic neuropathy. Aliment Pharmacol Ther 1991; 5:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/25\">",
"      Jian R, Ducrot F, Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/26\">",
"      Feldman M, Smith HJ. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo. Gastroenterology 1987; 92:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/27\">",
"      Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/28\">",
"      Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994; 106:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/29\">",
"      McCallum RW, Valenzuela G, Polepalle S, Spyker D. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 1991; 258:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/30\">",
"      Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 2010; 31:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/31\">",
"      Hyett B, Martinez FJ, Gill BM, et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology 2009; 137:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/32\">",
"      Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/33\">",
"      Sugumar A, Singh A, Pasricha PJ. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis. Clin Gastroenterol Hepatol 2008; 6:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/34\">",
"      Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999; 94:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/35\">",
"      Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1998; 20:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/36\">",
"      Drolet B, Rousseau G, Daleau P, et al. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102:1883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/37\">",
"      Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/38\">",
"      Woodward MN, Spicer RD. Intrapyloric botulinum toxin injection improves gastric emptying. J Pediatr Gastroenterol Nutr 2003; 37:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/39\">",
"      Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002; 55:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/40\">",
"      Lacy BE, Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/41\">",
"      Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/42\">",
"      Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/43\">",
"      Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/44\">",
"      Pitt HA, Mann LL, Berquist WE, et al. Chronic intestinal pseudo-obstruction. Management with total parenteral nutrition and a venting enterostomy. Arch Surg 1985; 120:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/45\">",
"      Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995; 90:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/46\">",
"      Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003; 98:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/47\">",
"      Karlstrom L, Kelly KA. Roux-Y gastrectomy for chronic gastric atony. Am J Surg 1989; 157:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/48\">",
"      Forstner-Barthell AW, Murr MM, Nitecki S, et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 1999; 3:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/49\">",
"      Mathias JR, Fernandez A, Sninsky CA, et al. Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology 1985; 88:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/50\">",
"      Miedema BW, Kelly KA, Camilleri M, et al. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology 1992; 103:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/51\">",
"      Tu BN, Kelly KA. Motility Disorders after Roux-en-Y Gastrojejunostomy. Obes Surg 1994; 4:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33576/abstract/52\">",
"      Noh SM. Improvement of the Roux limb function using a new type of \"uncut Roux\" limb. Am J Surg 2000; 180:37.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2532 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-708A4DD6E0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33576=[""].join("\n");
var outline_f32_50_33576=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIETARY MODIFICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hydration and nutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Jejunal feeding tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GLYCEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Macrolide antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H128227567\">",
"      - Erythromycin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H128227574\">",
"      - Azithromycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cisapride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Metoclopramide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Domperidone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antiemetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Botulinum toxin injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DECOMPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Roux-en-Y stasis syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      GASTRIC ELECTRICAL STIMULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acute exacerbations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Chronic or subacute",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2532\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2532|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?29/29/30161\" title=\"algorithm 1\">",
"      Management gastroparesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2532|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9950\" title=\"table 1\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=related_link\">",
"      Chronic intestinal pseudo-obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=related_link\">",
"      Diabetic autonomic neuropathy of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31574?source=related_link\">",
"      Electrical stimulation for gastroparesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/35/41529?source=related_link\">",
"      Gastrointestinal manifestations of systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7226?source=related_link\">",
"      Malignancy-associated gastroparesis: Pathophysiology and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14312?source=related_link\">",
"      Pathogenesis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/60/8130?source=related_link\">",
"      Patient information: Gastroparesis (delayed gastric emptying) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33577="Bulimia nervosa in adults: Clinical features, diagnosis, and assessment";
var content_f32_50_33577=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bulimia nervosa in adults: Clinical features, diagnosis, and assessment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Scott Engel, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Kristine Steffen, PharmD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33577/contributors\">",
"     James E. Mitchell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Joel Yager, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?32/50/33577/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?32/50/33577/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?32/50/33577/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H22668222\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bulimia nervosa is characterized by recurrent episodes of binge eating and inappropriate compensatory behaviors, as well as comorbid psychopathology [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. In the United States, it is estimated that the lifetime prevalence of bulimia nervosa is 1.5 percent in women, and 0.5 percent in men [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2\">",
"     2",
"    </a>",
"    ]. The illness was first distinguished from anorexia nervosa in 1979 [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, differential diagnosis, comorbid psychopathology, and assessment of bulimia nervosa are reviewed here. The epidemiology, pathogenesis, medical complications and their management, treatment, and outcome of bulimia nervosa are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"       \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"       \"Eating disorders: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8041571\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The core features of bulimia nervosa are binge eating (ie, eating an amount of food that is definitely larger than most people would eat under similar circumstances), inappropriate compensatory behavior to prevent weight gain, and excessive concern about body weight and shape [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. The prototypic sequence of behavior in bulimia nervosa consists of [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Caloric restriction",
"     </li>",
"     <li>",
"      Binge eating",
"     </li>",
"     <li>",
"      Self-induced vomiting",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The binge eating episode triggers further caloric restriction, which leads to intense hunger and increases the probability of an additional binge eating episode. This pattern of behavior is known as the Restriction Model [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/4\">",
"     4",
"    </a>",
"    ]. As part of the dietary restraint that occurs between binges, patients eat low-calorie food and avoid food that is perceived to be fattening or likely to trigger a binge [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other antecedents to bingeing and purging include dysphoria and interpersonal stressors (Dual Pathway Model) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Thus, several treatments target negative affect and stressors as a precipitant for binge-purge behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/8\">",
"     8",
"    </a>",
"    ]. Dysphoria also occurs after a binge, along with remorse and self-loathing.",
"   </p>",
"   <p>",
"    An epidemiologic study found that bulimia nervosa is more common in females than males by a ratio of 3:1, and the median age of onset is 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2\">",
"     2",
"    </a>",
"    ]. At least mild psychosocial impairment (home, work, personal life, or social life) was observed in 78 percent of patients, and severe impairment was present in 16 percent. &nbsp;",
"   </p>",
"   <p>",
"    The body weight of patients with bulimia nervosa is usually within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. However, some patients may be mildly underweight, and others overweight or obese.",
"   </p>",
"   <p>",
"    Common physical signs in bulimia nervosa include hypotension, tachycardia, and dry skin [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In addition, menstrual irregularities are seen in approximately one-third to one-half of female patients [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/12\">",
"     12",
"    </a>",
"    ]. Many patients induce vomiting after binge eating, which can erode dental enamel and cause hypertrophy of the parotid glands and &ldquo;puffy&rdquo; cheeks [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1,10,11\">",
"     1,10,11",
"    </a>",
"    ]. Regular vomiting can also cause dehydration, hypokalemia, hypochloremia, and metabolic alkalosis. Medical complications and their management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"     \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bulimia nervosa is usually accompanied by additional psychopathology. (See",
"    <a class=\"local\" href=\"#H15893577\">",
"     'Comorbid psychopathology'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22668229\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Psychiatric Association's Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) and the World Health Organization's International Classification of Diseases-10th Revision (ICD-10) can each be used to diagnose bulimia nervosa. The criteria used by each system are largely the same.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88601455\">",
"    <span class=\"h2\">",
"     Diagnostic and Statistical Manual, Fourth Edition, Text Revision",
"    </span>",
"    &nbsp;&mdash;&nbsp;A DSM-IV-TR diagnosis of bulimia nervosa requires all of the following criteria (",
"    <a class=\"graphic graphic_table graphicRef70006 \" href=\"UTD.htm?2/46/2796\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent episodes of binge eating, defined as eating an unusually large amount of food in a discrete period of time (eg, two hours). Patients feel they cannot control their eating during the episode.",
"     </li>",
"     <li>",
"      Recurrent inappropriate compensatory behavior to prevent weight gain",
"     </li>",
"     <li>",
"      Binge eating and inappropriate compensatory behaviors occur at least two times per week for three months",
"     </li>",
"     <li>",
"      The patient&rsquo;s self-evaluation is unduly influenced by body shape and weight",
"     </li>",
"     <li>",
"      The disturbance does not occur exclusively during an episode of anorexia nervosa",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The key element of a binge is the excessive amount of food that is consumed; objectively, a binge is equivalent to at least two meals [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/13\">",
"     13",
"    </a>",
"    ] or about 2000 kcal [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/14\">",
"     14",
"    </a>",
"    ]. The clinician should consider the context of a meal in deciding whether the patient is binge eating. As an example, an amount of food that is excessive for a typical meal may be regarded as normal during a celebration or holiday [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. The episode of bingeing usually continues until the patient is uncomfortable or painfully full. The type of food varies and although a binge often includes high-calorie sweets, patients do not appear to crave any specific nutrient. In addition, the fraction of calories derived from protein, carbohydrates, and fat during a binge is similar to the fractions consumed during a meal by an individual without bulimia nervosa.",
"   </p>",
"   <p>",
"    Patients feel they lose control over their eating during a binge, which may occur in either a frenzied or dissociative state [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. However, this lack of control is not absolute. Patients are usually ashamed of their behavior and try to conceal it, and will usually stop bingeing if someone unexpectedly enters the room.",
"   </p>",
"   <p>",
"    DSM-IV-TR describes two subtypes of bulimia nervosa &ndash; purging and non-purging &ndash; depending upon the inappropriate compensatory behavior used to avoid weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. The purging type is characterized by self-induced vomiting or misuse of laxatives, diuretics, or enemas. The most common behavior in patients treated at eating disorder clinics is self-induced vomiting, using the fingers to stimulate the gag reflex. Ipecac syrup (emetine) may be ingested to induce vomiting, and chronic use may cause cardiac and skeletal myopathy. Some patients become so adept that they can vomit at will. Non-purging bulimia nervosa is generally characterized by fasting for a day or longer, or excessive exercise such that it interferes with important activities, or occurs at inappropriate times, in inappropriate settings, or despite injury. In addition, thyroid hormone may be misused and patients with bulimia nervosa and diabetes may omit or reduce insulin doses. Medical complications of purging are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link&amp;anchor=H27959316#H27959316\">",
"     \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\", section on 'Medical complications of bulimia nervosa'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88601462\">",
"    <span class=\"h2\">",
"     International Classification of Diseases - 10 Revision",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic criteria for bulimia nervosa according to the ICD-10 overlap considerably with the DSM-IV-TR criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]. An ICD-10 diagnosis of bulimia nervosa requires all of the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A persistent preoccupation with eating and an irresistible craving for food; the patient eats large amounts of food in short periods of time.",
"     </li>",
"     <li>",
"      The patient counteracts the \"fattening\" effects of overeating by one or more of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Self-induced vomiting",
"     </li>",
"     <li>",
"      Intermittent periods of starvation",
"     </li>",
"     <li>",
"      Abuse of purgatives (laxatives), appetite suppressants, thyroid preparations, or diuretics. Patients with bulimia nervosa and diabetes may neglect using insulin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A morbid dread of fatness; the patient sets a sharply defined weight threshold, well below the premorbid weight that constitutes the optimum weight in the opinion of the physician.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The primary distinction between ICD-10 and DSM-IV-TR is that ICD-10 emphasizes the relationship between bulimia nervosa and anorexia nervosa, as illustrated by the last ICD-10 criterion for bulimia nervosa. In addition, the text that accompanies the ICD-10 diagnostic criteria stipulates that bulimia nervosa is usually the sequel to anorexia nervosa, and that the two disorders share psychopathologic features (eg, fear of gaining weight or becoming fat and dissatisfaction with one&rsquo;s body) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/15\">",
"     15",
"    </a>",
"    ]. ICD-10 does not formally distinguish purging and non-purging subtypes of bulimia nervosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22668250\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some symptoms of bulimia nervosa (eg, hyperphagia) overlap with symptoms of other psychiatric and medical illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1,14\">",
"     1,14",
"    </a>",
"    ]. However, these other illnesses generally do not include the inappropriate compensatory behaviors to prevent weight gain (purging, fasting, or excessive exercise) or excessive preoccupation with weight and body shape seen in bulimia nervosa. Some of the illnesses that resemble bulimia nervosa can also occur in conjunction with bulimia nervosa (eg, unipolar major depression and borderline personality disorder). (See",
"    <a class=\"local\" href=\"#H15893577\">",
"     'Comorbid psychopathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258842664\">",
"    <span class=\"h2\">",
"     Psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorexia nervosa, binge eating disorder, major depressive disorder, and borderline personality disorder can resemble bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. The greatest amount of overlap exists between anorexia nervosa and bulimia nervosa, and distinguishing the two is critical for treatment; body weight is usually normal in bulimia nervosa and low in anorexia nervosa. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258842622\">",
"    <span class=\"h3\">",
"     Anorexia nervosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorexia nervosa and bulimia nervosa are both marked by overvaluation of body shape and weight. In addition, binge eating and purging occur as part of anorexia nervosa,",
"    <span class=\"nowrap\">",
"     binge-eating/purging",
"    </span>",
"    type. The key distinguishing feature of anorexia nervosa is an abnormally low body weight less than 85 percent of what is expected for the patient&rsquo;s age and height. By contrast, patients with bulimia nervosa usually maintain a body weight at or above a minimally normal level; if they are underweight, it is only to a mild degree [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. Secondarily, the severe weight loss that occurs in anorexia nervosa is accompanied by anatomic and physiologic sequelae that are not found in bulimia nervosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H3#H3\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Anorexia nervosa'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=see_link\">",
"     \"Anorexia nervosa in adults and adolescents: Medical complications and their management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"     \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these distinctions, anorexia nervosa and bulimia nervosa are related disorders and many experts acknowledge that the line between the two diagnoses is sometimes not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. In addition, the diagnosis for patients can change from one disorder to the other. An observational study followed 88 patients with anorexia nervosa for up to seven years and found that at some point, 34 percent met criteria for bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/20\">",
"     20",
"    </a>",
"    ]. Of the 128 patients with bulimia nervosa at study intake, 14 percent crossed over to a diagnosis of anorexia nervosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258842679\">",
"    <span class=\"h3\">",
"     Binge eating disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of binge eating occur in both bulimia nervosa and binge-eating disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. The two disorders are distinguished by the inappropriate compensatory behaviors that regularly occur as part of bulimia nervosa, but are absent or infrequent in binge-eating disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H6#H6\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Binge-eating disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258842630\">",
"    <span class=\"h3\">",
"     Unipolar major depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overeating often occurs in major depressive disorder with atypical features [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. However, neither unhealthy compensatory behavior to prevent weight gain nor excessive preoccupation with weight and body shape is present in major depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H905216\">",
"    <span class=\"h3\">",
"     Borderline personality disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Binge eating is an example of the impulsivity that marks borderline personality disorder; suicidality and disturbed identity are other features that overlap with bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the presence of inappropriate compensatory behavior indicates the diagnosis of bulimia nervosa. In addition, the identity disturbance of patients with bulimia nervosa involves weight and body shape, whereas in borderline personality the disturbance is more likely to involve goals, values, and vocational aspirations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/19/10553?source=see_link&amp;anchor=H16#H16\">",
"     \"Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258842750\">",
"    <span class=\"h2\">",
"     Medical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperphagia can occur in medical disorders such as Prader-Willi syndrome and Klein-Levin syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/14\">",
"     14",
"    </a>",
"    ]. Prader-Willi syndrome is a genetic disorder marked by hyperphagia, obsession with food, and obesity, as well as cognitive impairment (usually mental retardation) and hypogonadism. Behavioral problems such as tantrums or oppositional behavior can also occur. Klein-Levin syndrome is a self-limited illness that usually affects adolescent males and is marked by increased appetite as well as hypersomnia and behavioral disturbances. Symptoms remit between episodes. Neither syndrome is accompanied by the inappropriate compensatory behaviors and over-concern with shape and weight seen in bulimia nervosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15893577\">",
"    <span class=\"h1\">",
"     COMORBID PSYCHOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with bulimia nervosa are often suicidal, and usually have a lifetime history of other psychiatric disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1,2,21\">",
"     1,2,21",
"    </a>",
"    ]. Every axis I disorder and personality disorder that is present should be diagnosed because of implications for treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86981101\">",
"    <span class=\"h2\">",
"     Suicidality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bulimia nervosa is often accompanied by suicidality, including suicidal ideation, action to prepare for an attempt, attempt or nonfatal self-harm, or death. A longitudinal follow-up (mean 18 years) of 906 patients with bulimia nervosa found that one percent committed suicide, which was seven times the rate in the general population (standardized mortality ratio 7, 95 percent CI 3-13) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/22\">",
"     22",
"    </a>",
"    ]. Reviews estimate that 25 to 40 percent of bulimia nervosa patients have a lifetime history of attempted suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In addition, impulsive nonfatal self-harm (eg, cutting or burning with a lit cigarette) is often seen. No consistent predictors of suicidality have been found across different studies, except that comorbid psychopathology such as substance use disorders often predicted suicide attempts [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/23-30\">",
"     23-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with suicidality should be seen more frequently and perhaps hospitalized, depending upon the estimated level of risk (",
"    <a class=\"graphic graphic_table graphicRef73092 \" href=\"UTD.htm?9/54/10094\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. A specific suicide plan of high lethality or intent indicates the need for hospitalization. Risk factors, evaluation, and management of suicidality are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=see_link\">",
"     \"Suicidal ideation and behavior in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15893599\">",
"    <span class=\"h2\">",
"     Axis I disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the rate of specific comorbid disorders differs between epidemiologic surveys and studies in clinical settings, there is general agreement that patients with bulimia nervosa usually suffer from comorbid axis I pathology, including [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2,33\">",
"     2,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anxiety disorders",
"     </li>",
"     <li>",
"      Mood disorders",
"     </li>",
"     <li>",
"      Substance use disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Screening for these comorbid disorders and their diagnostic criteria are discussed separately.",
"   </p>",
"   <p>",
"    A nationally representative epidemiologic survey in the United States estimated that 95 percent of patients with bulimia nervosa had a lifetime history of at least one comorbid Axis I disorder, and that 64 percent had three or more comorbid disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2\">",
"     2",
"    </a>",
"    ]. Anxiety disorders were most common and found in 81 percent of patients with bulimia nervosa, mood disorders were found in 71 percent, impulse control disorders in 64 percent, and substance use disorders in 37 percent (",
"    <a class=\"graphic graphic_table graphicRef63449 \" href=\"UTD.htm?21/13/21724\">",
"     table 3",
"    </a>",
"    ). The most frequent specific disorders were unipolar major depression and specific phobia, both of which were found in 50 percent of patients with bulimia nervosa. The lifetime rates for these comorbidities in patients with bulimia nervosa exceed the rates in the general population. As an example, the estimated lifetime prevalence of unipolar major depression in the general population is 23 percent and for specific phobia is 13 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comorbid axis I pathology is also frequent in clinical settings. A study at academically-affiliated eating disorder clinics found that among 282 patients with bulimia nervosa, the lifetime prevalence of at least one comorbid anxiety disorder was 68 percent, including obsessive-compulsive disorder (lifetime prevalence 40 percent), social phobia (16 percent), posttraumatic stress disorder (13 percent), and specific phobia (12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/33\">",
"     33",
"    </a>",
"    ]. Other similar studies found a lifetime history of unipolar major depression occurred in 73 percent of the patients with bulimia nervosa, alcohol abuse or dependence in 46 percent, and impulse control disorders 21 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The syndrome of bulimia nervosa usually begins prior to the onset of a comorbid mood or substance use disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2,36\">",
"     2,36",
"    </a>",
"    ]. Conversely, comorbid anxiety or impulse control disorders usually predate bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/2,37\">",
"     2,37",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Comorbid axis I pathology is associated with a poorer prognosis for bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. However, successful treatment of bulimia nervosa often resolves comorbid anxiety and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15893660\">",
"    <span class=\"h2\">",
"     Personality disorders and traits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid personality disorders and traits are usually present in bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a review of 10 studies that used diagnostic interviews, the most common personality disorders in patients with bulimia nervosa were [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/40\">",
"     40",
"    </a>",
"    ]: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Borderline (21 percent of patients with bulimia nervosa)",
"     </li>",
"     <li>",
"      Avoidant (19 percent)",
"     </li>",
"     <li>",
"      Dependent (10 percent)",
"     </li>",
"     <li>",
"      Paranoid (10 percent)",
"     </li>",
"     <li>",
"      Histrionic (9 percent)",
"     </li>",
"     <li>",
"      Obsessive-compulsive (9 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients meet criteria for more than one personality disorder. The classification, diagnosis, and treatment of personality disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=see_link\">",
"     \"Personality disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with bulimia nervosa may have comorbid personality pathology that is not severe enough to meet criteria for a personality disorder, but nevertheless causes distress and impairs functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31\">",
"     31",
"    </a>",
"    ]. This psychopathology includes such traits as [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/40\">",
"     40",
"    </a>",
"    ]: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Impulsivity &ndash; acting without thought of consequences, failing to resist a drive or temptation that is harmful",
"     </li>",
"     <li>",
"      Perfectionism &ndash; pursuing unrealistically high standards despite the occurrence of adverse consequences",
"     </li>",
"     <li>",
"      Compulsivity &ndash; need for order, symmetry, exactness, and control",
"     </li>",
"     <li>",
"      Narcissism &ndash; excessive concern with physical appearance, need for admiration and external validation from others",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Multiple traits are often found in the same patient with bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/41\">",
"     41",
"    </a>",
"    ]. One model hypothesizes that personality traits form three distinct patterns of comorbid personality pathology in patients with bulimia nervosa, consisting of emotional dysregulation and impulsivity, emotional inhibition and interpersonal avoidance, and perfectionism and achievement [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognostic significance of comorbid personality pathology is not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/40,43\">",
"     40,43",
"    </a>",
"    ]. Some studies have found that bulimia nervosa patients with comorbid personality disorders or traits have a worse outcome compared to patients without personality pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/38,42,44,45\">",
"     38,42,44,45",
"    </a>",
"    ], whereas other studies have found no significant difference [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22668257\">",
"    <span class=\"h1\">",
"     ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial clinical evaluation of patients with a possible diagnosis of bulimia nervosa includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. The clinical interview may be augmented with a self-report screening measure and a structured interviewing instrument. The initial assessment should address the clinical features, diagnostic criteria, and comorbid psychopathology of bulimia nervosa, and may require multiple interviews [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31\">",
"     31",
"    </a>",
"    ]. Subsequently, the clinician should monitor the patient&rsquo;s response to treatment and assess the patient for new illnesses. &nbsp;",
"   </p>",
"   <p>",
"    Establishing rapport with the patient helps elicit information. Patients are often ashamed of the disorder and may attempt to hide it from clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/50\">",
"     50",
"    </a>",
"    ]. At the beginning of the interview, simple questions about the patient&rsquo;s age, occupation, marital status, and referral source can put the patient at ease. In addition, directed and focused questions about eating disorder psychopathology may be helpful for patients who do not respond to open-ended questions [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/21\">",
"     21",
"    </a>",
"    ]. However, it is important to avoid undermining the interview by asking direct questions prematurely, and to allow the patient to describe their illness from their own point of view. Conveying a nonjudgmental and knowledgeable attitude is also helpful. Collateral information should be sought from family members, who may report the presence of vomitus in the house, finding laxatives or diuretics, or the patient regularly departing to the bathroom immediately after meals.",
"   </p>",
"   <p>",
"    The patient&rsquo;s medical status should also be evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/51\">",
"     51",
"    </a>",
"    ]. Assessing and managing the medical complications of bulimia nervosa are discussed separately. (See",
"    <a class=\"local\" href=\"#H8041571\">",
"     'Clinical features'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"     \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86979060\">",
"    <span class=\"h2\">",
"     Screening instruments",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic interview can be facilitated by first administering a self-report screening instrument [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/52\">",
"     52",
"    </a>",
"    ]. Patients who screen positive for an eating disorder should be asked about the DSM-IV-TR diagnostic criteria for bulimia nervosa and anorexia nervosa. Self-report instruments can save interviewer time, but are more prone to yielding false positives than clinician-administered instruments. (See",
"    <a class=\"local\" href=\"#H88601455\">",
"     'Diagnostic and Statistical Manual, Fourth Edition, Text Revision'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H3#H3\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Anorexia nervosa'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the available self-report measures, we suggest the SCOFF, which is a five-item self-report measure that screens for eating disorders; the SCOFF is discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H14#H14\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Screening tools'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An alternative self-report measure is the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (",
"    <a class=\"graphic graphic_table graphicRef82674 \" href=\"UTD.htm?21/32/22019\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/55\">",
"     55",
"    </a>",
"    ]. Whereas most screening instruments require a follow-up interview to make the diagnosis, the Patient Health Questionnaire both screens for and provides a DSM-IV diagnosis for bulimia nervosa, as well as depressive, anxiety, alcohol, and somatoform disorders. It was specifically designed for use in primary care, is fully self-administered by the patient, has good diagnostic validity overall (sensitivity 75 percent, specificity 90 percent), excellent diagnostic validity for bulimia nervosa (sensitivity 89 percent, specificity 96 percent), and the median physician time to review the results is one to two minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7789030\">",
"    <span class=\"h2\">",
"     Clinical interview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assessment of the psychiatric history and mental status should include questions about [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31,56,57\">",
"     31,56,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Height and weight",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Current &ndash; Clinicians should measure weight and height, as well as ask about them, because the patient&rsquo;s self-report is often unreliable. Body mass index (",
"      <a class=\"external\" href=\"file://www.uptodate.com/contents/calculator-body-mass-index-quetelets-index?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) and percent ideal body weight (",
"      <a class=\"external\" href=\"file:__www.uptodate.com_contents_image?imageKey=PSYCH_30081\">",
"       table 2",
"      </a>",
"      ) should then be determined for comparison to population norms.",
"     </li>",
"     <li>",
"      Lifetime highest and lowest weights at adult height, patterns of weight fluctuation",
"     </li>",
"     <li>",
"      Desired weight",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Frequency of self-weighing",
"     </li>",
"     <li>",
"      Food intake patterns when patients are not binge eating",
"     </li>",
"     <li>",
"      Present and past eating disorder symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dietary restriction",
"     </li>",
"     <li>",
"      Binge eating behavior, including frequency, types and amounts of food eaten, and whether patients feel they cannot control their eating during binges",
"     </li>",
"     <li>",
"      Compensatory behaviors such as purging (eg, self-induced vomiting or misuse of laxatives, enemas, diuretics, or diet pills), prolonged fasting, excessive exercise, and chewing and spitting out food",
"     </li>",
"     <li>",
"      Attitudes about body weight and shape, food, and eating",
"     </li>",
"     <li>",
"      Ritualistic eating behaviors, eg, cutting food into extremely small pieces or refusing to mix different types or colors of food on the plate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Level of self-esteem and the degree to which it depends upon body weight and shape",
"     </li>",
"     <li>",
"      Current and past suicidal ideation and behavior",
"     </li>",
"     <li>",
"      Comorbid disorders, such as anxiety, mood, impulse control, alcohol and substance use, and personality disorders",
"     </li>",
"     <li>",
"      Psychosocial functioning",
"     </li>",
"     <li>",
"      Prior treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Psychotherapy",
"     </li>",
"     <li>",
"      Pharmacotherapy",
"     </li>",
"     <li>",
"      Self-help groups &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family history of eating disorders and other psychopathology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Suicidality and comorbid disorders are discussed separately. (See",
"    <a class=\"local\" href=\"#H15893577\">",
"     'Comorbid psychopathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In discussing onset of bulimia nervosa, the clinician should ask about interpersonal problems at that time [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/31\">",
"     31",
"    </a>",
"    ]. However, family members should not be blamed for causing the illness; there is no evidence that families cause eating disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7789016\">",
"    <span class=\"h2\">",
"     Structured instruments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structured, interviewer-administered instruments are available for diagnosing bulimia nervosa and other eating disorders, but are seldom used in routine clinical practice. Validated instruments include the Eating Disorder Examination (the gold-standard for establishing eating disorder diagnoses) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]; Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Patient Edition, Eating Disorders Module [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/61\">",
"     61",
"    </a>",
"    ]; and the Structured Interview for Anorexic and Bulimic Disorders for expert rating [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. These instruments systematically assess each criterion for every eating disorder. All have good to excellent reliability and validity, which are mostly a function of interviewer training and experience. A structured instrument enables the interviewer to clarify ambiguous or contradictory responses, and may help differentiate the diagnosis of bulimia nervosa from anorexia nervosa. However, these instruments are labor intensive and generally reserved for specialized evaluation, treatment, or research settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H930938\">",
"    <span class=\"h2\">",
"     Measurement based care",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that clinicians ask patients at each visit how many episodes of binge-eating and purging occurred each week since the last visit. Measurement based care can help identify nonresponders and detect residual symptoms. Self-report measures may also be used to assess change in symptoms over time [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/52\">",
"     52",
"    </a>",
"    ]. Commonly used instruments include the Bulimia Test-Revised (BULIT-R; 36 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/64\">",
"     64",
"    </a>",
"    ], Eating Disorder Inventory-3 (EDI-3; 91 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/65\">",
"     65",
"    </a>",
"    ], Body Shape Questionnaire (34 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/66\">",
"     66",
"    </a>",
"    ], Three-Factor Eating Questionnaire (TFEQ; 51 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/67\">",
"     67",
"    </a>",
"    ], Eating Disorders Questionnaire (EDQ; 108 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/68\">",
"     68",
"    </a>",
"    ], and the Eating Disorder Examination-Questionnaire (EDE-Q; 38 items) [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/69\">",
"     69",
"    </a>",
"    ]. In addition, new technologies such as computers and smart phones can be used to assess patients via email and text messaging [",
"    <a class=\"abstract\" href=\"UTD.htm?32/50/33577/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/37/26194?source=see_link\">",
"       \"Patient information: Bulimia nervosa (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8040962\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The core clinical features of bulimia nervosa are binge eating (ie, eating an amount of food that is definitely larger than most people would eat under similar circumstances) and inappropriate compensatory behavior to prevent weight gain. The prototypic sequence of behavior in bulimia nervosa consists of caloric restriction, binge eating, and self-induced vomiting. (See",
"      <a class=\"local\" href=\"#H8041571\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Body weight is usually within the normal range, but some patients may be mildly underweight, and others overweight or obese. In addition, common physical signs in bulimia nervosa include hypotension, tachycardia, and dry skin. Menstrual irregularities are seen in approximately one-third to one-half of female patients. Regular vomiting can erode dental enamel, and cause hypertrophy of the parotid glands, dehydration, hypokalemia, hypochloremia, and metabolic alkalosis. Medical complications and their management are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"       \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H8041571\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of bulimia nervosa according to the Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) is summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef70006 \" href=\"UTD.htm?2/46/2796\">",
"       table 1",
"      </a>",
"      ). The diagnostic criteria of the International Classification of Diseases-10th Revision (ICD-10) are largely the same, although ICD-10 places a greater emphasis upon the relationship between bulimia nervosa and anorexia nervosa. (See",
"      <a class=\"local\" href=\"#H22668229\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients inappropriately compensate for a binge by vomiting (using the fingers to stimulate the gag reflex or ingesting ipecac syrup); abusing laxatives, diuretics, thyroid hormone, or enemas; fasting;",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exercising excessively. Patients with bulimia nervosa and diabetes may omit or reduce insulin doses. (See",
"      <a class=\"local\" href=\"#H88601455\">",
"       'Diagnostic and Statistical Manual, Fourth Edition, Text Revision'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is substantive overlap between anorexia nervosa and bulimia nervosa, however body weight is usually low in the former and normal in the latter. Other disorders which may be considered in the differential diagnosis of bulimia nervosa typically do not present with either inappropriate compensatory behavior to prevent weight gain or excessive preoccupation with weight and body shape. (See",
"      <a class=\"local\" href=\"#H22668250\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with bulimia nervosa are often suicidal, and usually have a lifetime history of comorbid psychiatric disorders, including anxiety, mood, impulse control, substance use, and personality disorders. Patients with suicidality should be seen more frequently and perhaps hospitalized, depending upon the estimated level of risk. A specific suicide plan of high lethality or intent indicates the need for hospitalization (",
"      <a class=\"graphic graphic_table graphicRef73092 \" href=\"UTD.htm?9/54/10094\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H86981101\">",
"       'Suicidality'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=see_link\">",
"       \"Suicidal ideation and behavior in adults\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H15893599\">",
"       'Axis I disorders'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15893660\">",
"       'Personality disorders and traits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic interview can be facilitated by first administering a self-report screening instrument. We suggest the SCOFF, which is a five-item self-report measure that screens for eating disorders. &nbsp;(See",
"      <a class=\"local\" href=\"#H86979060\">",
"       'Screening instruments'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H14#H14\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Screening tools'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The assessment of the patient&rsquo;s psychiatric history and mental status should include questions about height, weight, frequency of self-weighing, meal patterns, present and past eating disorder symptoms (dietary restriction; binge eating; compensatory behaviors such as purging, fasting, and exercise; attitudes about body weight and shape, food, and eating; and ritualistic eating behaviors), suicidality, comorbid psychiatric disorders, psychosocial functioning, and family psychiatric history. (See",
"      <a class=\"local\" href=\"#H7789030\">",
"       'Clinical interview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinicians should ask patients at each visit how many episodes of binge-eating and purging occurred each week since the last visit. (See",
"      <a class=\"local\" href=\"#H930938\">",
"       'Measurement based care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/2\">",
"      Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/3\">",
"      Russell G. Bulimia nervosa: an ominous variant of anorexia nervosa. Psychol Med 1979; 9:429.",
"     </a>",
"    </li>",
"    <li>",
"     Lowe, MR. Dietary restraint and overeating. In: Eating Disorders and Obesity, 2, Fairburn, CG, Browell, KD (Eds), The Guilford Press, New York 2002. p.88.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/5\">",
"      Stice E. A prospective test of the dual-pathway model of bulimic pathology: mediating effects of dieting and negative affect. J Abnorm Psychol 2001; 110:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/6\">",
"      Fox JR, Power MJ. Eating disorders and multi-level models of emotion: an integrated model. Clin Psychol Psychother 2009; 16:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/7\">",
"      Stice, E, Shaw, H, Nemeroff, C. Dual pathway model of bulimia nervosa: Longitudinal support for dietary restraint and affect-regulation mechanisms. J Soc Clin Psychol 1998; 17:129.",
"     </a>",
"    </li>",
"    <li>",
"     Wonderlich, SA, Mitchell, JE, Peterson, CB, Crow, S. Integrative cognitive therapy for bulimic behavior. In: Eating Disorders: Innovative directions in research and practice, Striegel-Moore RH, Smolak L (Eds), American Psychological Association, Washington, DC 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/9\">",
"      Field AE, Camargo CA Jr, Taylor CB, et al. Overweight, weight concerns, and bulimic behaviors among girls and boys. J Am Acad Child Adolesc Psychiatry 1999; 38:754.",
"     </a>",
"    </li>",
"    <li>",
"     Mehler, PS, Anderson, AE. Eating Disorders: A guide to medical care and complications, 2nd ed, The Johns Hopkins University Press, Baltimore, MD 2010.",
"    </li>",
"    <li>",
"     Mehler, PS, Birmingham, LC, Crow, SJ, Jahraus, JP. Medical complications of eating disorders. In: The Treatment of Eating Disorders: A Clinical Handbook, Grilo, CM, Mitchell, JE (Eds), The Guilford Press, New York 2010. p.66.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/12\">",
"      Gendall KA, Bulik CM, Joyce PR, et al. Menstrual cycle irregularity in bulimia nervosa. Associated factors and changes with treatment. J Psychosom Res 2000; 49:409.",
"     </a>",
"    </li>",
"    <li>",
"     Agras WS. Treatment of eating disorders. In: The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth Edition, Schatzberg AF, Nemeroff CB (Eds), American Psychiatric Publishing, Inc., Washington, DC 2009. p.1231.",
"    </li>",
"    <li>",
"     Devlin, MJ, Jahraus, JP, DiMarco, ID. Eating disorders. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine, Second Edition, Levenson, JL (Eds), American Psychiatric Publishing, Inc, Washington, DC 2011. p.305.",
"    </li>",
"    <li>",
"     The ICD-10 Classification of Mental and Behavioral Disorders file://www.who.int/classifications/icd/en/bluebook.pdf (Accessed on January 04, 2011).",
"    </li>",
"    <li>",
"     Walsh, BT, Satir, DA. Diagnostic issues. In: Assessment of Eating Disorders, Mitchell JE, Peterson CB (Eds), Guilford Publications, 2005. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/17\">",
"      Kaye WH, Devlin B, Barbarich N, et al. Genetic analysis of bulimia nervosa: methods and sample description. Int J Eat Disord 2004; 35:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/18\">",
"      Birmingham CL, Touyz S, Harbottle J. Are anorexia nervosa and bulimia nervosa separate disorders? Challenging the 'transdiagnostic' theory of eating disorders. Eur Eat Disord Rev 2009; 17:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/19\">",
"      Eddy KT, Dorer DJ, Franko DL, et al. Should bulimia nervosa be subtyped by history of anorexia nervosa? A longitudinal validation. Int J Eat Disord 2007; 40 Suppl:S67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/20\">",
"      Eddy KT, Dorer DJ, Franko DL, et al. Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry 2008; 165:245.",
"     </a>",
"    </li>",
"    <li>",
"     Crow, SJ, Brandenburg, B. Diagnosis, assessment, and treatment planning for bulimia nervosa. In: The Treatment of Eating Disorders, Grilo, CM, Mitchell, JE (Eds), The Guilford Press, New York 2010. p.28.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/22\">",
"      Crow SJ, Peterson CB, Swanson SA, et al. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry 2009; 166:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/23\">",
"      Franko DL, Keel PK. Suicidality in eating disorders: occurrence, correlates, and clinical implications. Clin Psychol Rev 2006; 26:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/24\">",
"      Sansone RA, Levitt JL. Self-harm behaviors among those with eating disorders: an overview. Eat Disord 2002; 10:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/25\">",
"      Franko DL, Keel PK, Dorer DJ, et al. What predicts suicide attempts in women with eating disorders? Psychol Med 2004; 34:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/26\">",
"      Forcano L, Fern&aacute;ndez-Aranda F, Alvarez-Moya E, et al. Suicide attempts in bulimia nervosa: personality and psychopathological correlates. Eur Psychiatry 2009; 24:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/27\">",
"      Favaro A, Santonastaso P, Monteleone P, et al. Self-injurious behavior and attempted suicide in purging bulimia nervosa: associations with psychiatric comorbidity. J Affect Disord 2008; 105:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/28\">",
"      Fedorowicz VJ, Falissard B, Foulon C, et al. Factors associated with suicidal behaviors in a large French sample of inpatients with eating disorders. Int J Eat Disord 2007; 40:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/29\">",
"      Pompili M, Girardi P, Tatarelli G, et al. Suicide and attempted suicide in eating disorders, obesity and weight-image concern. Eat Behav 2006; 7:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/30\">",
"      Anderson CB, Carter FA, McIntosh VV, et al. Self-harm and suicide attempts in individuals with bulimia nervosa. Eat Disord 2002; 10:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/31\">",
"      American Psychiatric Association. Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry 2006; 163:4.",
"     </a>",
"    </li>",
"    <li>",
"     Eating Disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa, and related eating disorders.",
"National Clinical Practice Guideline Number CG9 file://guidance.nice.org.uk/CG9/Guidance/pdf/English (Accessed on January 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/33\">",
"      Kaye WH, Bulik CM, Thornton L, et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004; 161:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/34\">",
"      Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/35\">",
"      Bulik CM, Klump KL, Thornton L, et al. Alcohol use disorder comorbidity in eating disorders: a multicenter study. J Clin Psychiatry 2004; 65:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/36\">",
"      Fernandez-Aranda F, Pinheiro AP, Tozzi F, et al. Symptom profile of major depressive disorder in women with eating disorders. Aust N Z J Psychiatry 2007; 41:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/37\">",
"      Fern&aacute;ndez-Aranda F, Pinheiro AP, Thornton LM, et al. Impulse control disorders in women with eating disorders. Psychiatry Res 2008; 157:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/38\">",
"      Milos GF, Spindler AM, Buddeberg C, Crameri A. Axes I and II comorbidity and treatment experiences in eating disorder subjects. Psychother Psychosom 2003; 72:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/39\">",
"      Fichter MM, Quadflieg N, Hedlund S. Long-term course of binge eating disorder and bulimia nervosa: relevance for nosology and diagnostic criteria. Int J Eat Disord 2008; 41:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/40\">",
"      Cassin SE, von Ranson KM. Personality and eating disorders: a decade in review. Clin Psychol Rev 2005; 25:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/41\">",
"      Engel SG, Corneliussen SJ, Wonderlich SA, et al. Impulsivity and compulsivity in bulimia nervosa. Int J Eat Disord 2005; 38:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/42\">",
"      Thompson-Brenner H, Westen D. Personality subtypes in eating disorders: validation of a classification in a naturalistic sample. Br J Psychiatry 2005; 186:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/43\">",
"      Grilo CM. Recent research of relationships among eating disorders and personality disorders. Curr Psychiatry Rep 2002; 4:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/44\">",
"      Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychiatry 1997; 154:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/45\">",
"      Steiger H, Stotland S. Prospective study of outcome in bulimics as a function of Axis-II comorbidity: long-term responses on eating and psychiatric symptoms. Int J Eat Disord 1996; 20:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/46\">",
"      Grilo CM, Sanislow CA, Shea MT, et al. The natural course of bulimia nervosa and eating disorder not otherwise specified is not influenced by personality disorders. Int J Eat Disord 2003; 34:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/47\">",
"      Rowe SL, Jordan J, McIntosh VV, et al. Impact of borderline personality disorder on bulimia nervosa. Aust N Z J Psychiatry 2008; 42:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/48\">",
"      Work Group on Psychiatric Evaluation, American Psychiatric Association Steering Committee on Practice Guidlines. Psychiatric evaluation of adults. Second edition. American Psychiatric Association. Am J Psychiatry 2006; 163:3.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition, 2006. file://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on July 18, 2011).",
"    </li>",
"    <li>",
"     Andersen, AE, Yager, J. Eating disorders. In: Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Volume I, Ninth Edition, Sadock, BJ, Sadock, VA, Ruiz P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2009. p.2128.",
"    </li>",
"    <li>",
"     Crow, S, Swigart, S. Medical assessment. In: Assessment of Eating Disorders, Mitchell, JE, Peterson, CB (Eds), Guilford Publications, New York 2005. p.120.",
"    </li>",
"    <li>",
"     Peterson CB, Mitchell JE. Self-report measures. In: Assessment of Eating Disorders, Mitchell JE, Peterson CB (Eds), Guilford Publications, New York 2005. p.98.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/53\">",
"      Morgan, JF, Reid, F, Lacey, JH. The SCOFF questionnaire: Assessment of a new screening tool for eating disorders. BR Med J 1999; 319:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/54\">",
"      Hill LS, Reid F, Morgan JF, Lacey JH. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 2010; 43:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/55\">",
"      Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282:1737.",
"     </a>",
"    </li>",
"    <li>",
"     Assessment of Eating Disorders, Mitchell, JE, Peterson, CB (Eds), Guilford Publications, New York 2005.",
"    </li>",
"    <li>",
"     Peterson, CB. Conducting the diagnostic interview. In: Assessment of Eating Disorders, Mitchell, JE, Peterson, CB (Eds), Guilford Publications, New York 2005. p.32.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/58\">",
"      Cooper, Z, Fairburn, C. The eating disorder examination: A semi-structured interview for the assessment of the specific psychopathology of eating disorders. Int J Eat Disord 1987; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/59\">",
"      Grilo, CM. The assessment and treatment of binge eating disorder. J Psychiatr Pract 1998; 4:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/60\">",
"      Sysko R, Walsh BT, Fairburn CG. Eating Disorder Examination-Questionnaire as a measure of change in patients with bulimia nervosa. Int J Eat Disord 2005; 37:100.",
"     </a>",
"    </li>",
"    <li>",
"     First MB, Spitzer RL, Miriam G, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P), Biometrics Research, New York State Psychiatric Institute, New York 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/62\">",
"      Fichter MM, Herpertz S, Quadflieg N, Herpertz-Dahlmann B. Structured Interview for Anorexic and Bulimic disorders for DSM-IV and ICD-10: updated (third) revision. Int J Eat Disord 1998; 24:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/63\">",
"      Fichter MM, Quadflieg N. Comparing self- and expert rating: a self-report screening version (SIAB-S) of the structured interview for anorexic and bulimic syndromes for DSM-IV and ICD-10 (SIAB-EX). Eur Arch Psychiatry Clin Neurosci 2000; 250:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/64\">",
"      Welch G, Thompson L, Hall A. The BULIT-R: its reliability and clinical validity as a screening tool for DSM-III-R bulimia nervosa in a female tertiary education population. Int J Eat Disord 1993; 14:95.",
"     </a>",
"    </li>",
"    <li>",
"     Garner DM, Olmstead MP, Polivy J. Eating Disorder Inventory-3 (EDI-3). In: Handbook of Psychiatric Measures, Rush Jr AJ, First MB, Blacker D (Eds), American Psychiatric Publishing, Inc, Washington, DC 2008. p.626.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/66\">",
"      Cooper, PJ, Taylor, MJ, Cooper, Z, et, al. The development and validation of the Body Shape Questionnaire. Int J Eat Disord 1987; 6:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/67\">",
"      Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/68\">",
"      Mitchell, JE, Specker, SM, de, Zwaan, M. Eating disorders questionnaire. Psychopharmacol Bull 1991; 21:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?32/50/33577/abstract/69\">",
"      Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord 1994; 16:363.",
"     </a>",
"    </li>",
"    <li>",
"     Engel SG, Wonderlich SA. New technologies in treatments for eating disorders. In: The Treatment of Eating Disorders: A Clinical Handbook, Grilo CM, Mitchell JE (Eds), The Guilford Press, New York 2010. p.500.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14709 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-00FF42CD0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33577=[""].join("\n");
var outline_f32_50_33577=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8040962\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22668222\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8041571\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22668229\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88601455\">",
"      Diagnostic and Statistical Manual, Fourth Edition, Text Revision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88601462\">",
"      International Classification of Diseases - 10 Revision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22668250\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258842664\">",
"      Psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258842622\">",
"      - Anorexia nervosa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258842679\">",
"      - Binge eating disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258842630\">",
"      - Unipolar major depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H905216\">",
"      - Borderline personality disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258842750\">",
"      Medical disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15893577\">",
"      COMORBID PSYCHOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86981101\">",
"      Suicidality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15893599\">",
"      Axis I disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15893660\">",
"      Personality disorders and traits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22668257\">",
"      ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86979060\">",
"      Screening instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7789030\">",
"      Clinical interview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7789016\">",
"      Structured instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H930938\">",
"      Measurement based care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8040962\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/14709\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14709|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/46/2796\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for bulimia nervosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/54/10094\" title=\"table 2\">",
"      Level of care guidelines for patients with eating disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/13/21724\" title=\"table 3\">",
"      Comorbidity of bulimia nervosa and other DSM-IV Axis I disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/32/22019\" title=\"table 4\">",
"      PHQ",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/19/10553?source=related_link\">",
"      Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=related_link\">",
"      Bulimia nervosa and binge eating disorder in adults: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/37/26194?source=related_link\">",
"      Patient information: Bulimia nervosa (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=related_link\">",
"      Personality disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=related_link\">",
"      Suicidal ideation and behavior in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_50_33578="EB simplex localized 1";
var content_f32_50_33578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86390%7EDERM%2F86391%7EDERM%2F86392%7EDERM%2F86393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86390%7EDERM%2F86391%7EDERM%2F86392%7EDERM%2F86393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Friction-induced bullae in epidermolysis bullosa simplex (EBS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blisters and erosions on mechanically exposed hands in localized EBS.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa simplex (EBS), localized",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Partly hemorrhagic blisters and erosions on mechanically exposed hands in localized EBS.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa simplex (EBS) of Dowling-Meara",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical herpetiform distribution of cutaneous lesions, including blisters, erosions, crusts, and atrophic scars, in EBS Dowling-Meara.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa simplex (EBS) of Dowling-Meara",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical herpetiform distribution of cutaneous lesions, including&nbsp;blisters, erosions, crusts, and atrophic scars, in EBS Dowling Meara.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33578=[""].join("\n");
var outline_f32_50_33578=null;
var title_f32_50_33579="Groups at high risk for influenza complications";
var content_f32_50_33579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Groups at high risk for influenza complications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Children &lt;2 years*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adults &ge;65 years of age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Persons with chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, hematologic (including sickle cell disease), metabolic (including diabetes mellitus), neurologic, neuromuscular, and neurodevelopmental disorders (including disorders of the brain, spinal cord, peripheral nerve and muscle such as cerebral palsy, epilepsy, stroke, intellectual disability [mental retardation], moderate to severe developmental delay, muscular dystrophy, or spinal cord injury)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Women who are pregnant or postpartum (within 2 weeks after delivery)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children &lt;19 years of age and receiving long-term aspirin therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Native Americans and Alaskan Natives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morbidly obese (body mass index [BMI] &ge;40 for adults or BMI &gt;2.33 standard deviations above the mean for children)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Residents of nursing homes and other chronic care facilities",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Although all children &lt;5 years of age&nbsp;are considered to be at higher risk for complications of influenza, the highest risk is for those &lt;2 years of age, with the highest hospitalization and death rates among infants &lt;6 months of age.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Centers for Disease Control and Prevention. 2011-2012 Influenza antiviral medications: Summary for clinicians. file://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed on June 28, 2012).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33579=[""].join("\n");
var outline_f32_50_33579=null;
var title_f32_50_33580="ASD treatment resources";
var content_f32_50_33580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Online resources for providers and families of children with autism spectrum disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Resource",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          American Academy of Pediatrics National Center for Medical Home Implementation",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.medicalhomeinfo.org/health/autism.html\" target=\"_blank\">",
"          www.medicalhomeinfo.org/health/autism.html",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information for families and providers, including a resource toolkit (for purchase)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Autism Society of America",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.autism-society.org\" target=\"_blank\">",
"          www.autism-society.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information about treatment, education, and advocacy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Autism Speaks Family Services Tool Kits",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.autismspeaks.org/docs/family_services_docs/100_day_kit.pdf\" target=\"_blank\">",
"          www.autismspeaks.org/docs/family_services_docs/100_day_kit.pdf",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"file://www.autismspeaks.org/family-services/tool-kits\" target=\"_blank\">",
"          www.autismspeaks.org/family-services/tool-kits",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information for families to make the best possible use of the 100 days following diagnosis with ASD; other tool kits are available to help with blood draws, dental visits, transitions, toilet training, education planning, etc",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          The Centers for Disease Control and Prevention's Autism Information Center",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.cdc.gov/ncbddd/autism/treatment.html\" target=\"_blank\">",
"          www.cdc.gov/ncbddd/autism/treatment.html",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information about treatment of ASD",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          First Signs",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.firstsigns.org\" target=\"_blank\">",
"          www.firstsigns.org",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"file://www.firstsigns.org/asd_video_glossary/asdvg_about.htm\" target=\"_blank\">",
"          www.firstsigns.org/asd_video_glossary/asdvg_about.htm",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information for providers and parents, including video clips showing early red flags for autism",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          The United Kingdom's National Autistic Society",
"         </strong>",
"        </p>",
"        <p>",
"         <a href=\"file://www.nas.org.uk\" target=\"_blank\">",
"          www.nas.org.uk",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information about ASD, services, and activities",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33580=[""].join("\n");
var outline_f32_50_33580=null;
var title_f32_50_33581="Chemo response saliv gland tum";
var content_f32_50_33581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemotherapy response in different histologies of salivary gland tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        Agent/regimen",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Histology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Adenoid cystic cancer",
"       </td>",
"       <td class=\"subtitle2\">",
"        Mucoepidermoid cancer",
"       </td>",
"       <td class=\"subtitle2\">",
"        Adenocarcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Number of responses/total number of patients, (percent)",
"       </td>",
"       <td class=\"subtitle3\">",
"        Number of responses/total number of patients, (percent)",
"       </td>",
"       <td class=\"subtitle3\">",
"        Number of responses/total number of patients, (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cisplatin",
"        <sup>",
"         [1,2]",
"        </sup>",
"       </td>",
"       <td>",
"        2/32 (6)",
"       </td>",
"       <td>",
"        1/5",
"       </td>",
"       <td>",
"        0/5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vinorelbine",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        2/13 (15)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        2/5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitoxantrone",
"        <sup>",
"         [4,5]",
"        </sup>",
"       </td>",
"       <td>",
"        5/50 (10)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epirubicin",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"       <td>",
"        2/20 (10)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"        <sup>",
"         [7]",
"        </sup>",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        2/5 (40)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paclitaxel",
"        <sup>",
"         [8]",
"        </sup>",
"       </td>",
"       <td>",
"        0/14",
"       </td>",
"       <td>",
"        3/14 (21)",
"       </td>",
"       <td>",
"        5/17 (29)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CAP or CAP/5-FU",
"        <sup>",
"         [7,9-14]",
"        </sup>",
"       </td>",
"       <td>",
"        12/43 (28)",
"       </td>",
"       <td>",
"        5/6 (83)",
"       </td>",
"       <td>",
"        23/37 (62)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/anthracycline &plusmn; 5 FU",
"        <sup>",
"         [15-18]",
"        </sup>",
"       </td>",
"       <td>",
"        6/19 (32)",
"       </td>",
"       <td>",
"        1/4",
"       </td>",
"       <td>",
"        8/14 (57)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophos/doxorubicin",
"        <sup>",
"         [7,19]",
"        </sup>",
"       </td>",
"       <td>",
"        2/6",
"       </td>",
"       <td>",
"        0/6",
"       </td>",
"       <td>",
"        1/1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/MTX/bleo",
"        <sup>",
"         [7,19]",
"        </sup>",
"       </td>",
"       <td>",
"        0/3",
"       </td>",
"       <td>",
"        2/3 (66)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/5-FU",
"        <sup>",
"         [20]",
"        </sup>",
"       </td>",
"       <td>",
"        0/11",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/vinorelbine",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        4/9 (44)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1/5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/doxorubicin/bleo",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        3/9 (33)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbo/paclitaxel",
"        <sup>",
"         [21,22]",
"        </sup>",
"       </td>",
"       <td>",
"        2/10 (20)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1/1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cis/gemcitabine",
"        <sup>",
"         [23]",
"        </sup>",
"       </td>",
"       <td>",
"        2/10 (20)",
"       </td>",
"       <td>",
"        1/4 (25)",
"       </td>",
"       <td>",
"        3/8 (38)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CAP: cyclophosphanide, doxorubicin, cisplatin; Cis: cisplatin; MTX: methotrexate; Bleo: bleomycin; Carbo: carboplatin; 5-FU: 5-fluorouracil.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Licitra, L; et al. Cancer 1991; 68:1874.",
"       </li>",
"       <li>",
"        de Haan, L; et al. Head Neck 1992; 14:273.",
"       </li>",
"       <li>",
"        Airoldi, M; et al. Cancer 2001; 91:541.",
"       </li>",
"       <li>",
"        Mattox, D; et al. Invest New Drugs 1990; 8:105.",
"       </li>",
"       <li>",
"        Verweij, J; et al. Ann Oncol 1996; 7:867.",
"       </li>",
"       <li>",
"        Vermorken, J; et al. Ann Oncol 1993; 4:785.",
"       </li>",
"       <li>",
"        Kaplan, M; et al. Otolaryngol Head Neck Surg 1986; 95:165.",
"       </li>",
"       <li>",
"        Gilbert, J; et al. Head Neck 2006; 28:197.",
"       </li>",
"       <li>",
"        Licitra, L; et al. Ann Oncol 1996; 7:640.",
"       </li>",
"       <li>",
"        Dreyfuss, A; et al. Cancer 1987; 60:2869.",
"       </li>",
"       <li>",
"        Creagan, E; et al. Cancer 1988; 62:2313.",
"       </li>",
"       <li>",
"        Belani, C; et al. Med Pediatr Oncol 1988; 16:197.",
"       </li>",
"       <li>",
"        Dimery, I; et al. J Clin Oncol 1990; 8:1056.",
"       </li>",
"       <li>",
"        Alberts, D; et al. Cancer 1981; 47:645.",
"       </li>",
"       <li>",
"        Airoldi, M; et al. Tumor 1989; 75:252.",
"       </li>",
"       <li>",
"        Venook, A; et al. J Clin Oncol 1987; 5:951.",
"       </li>",
"       <li>",
"        Tsukuda, M; et al. J Cancer Res Clin Oncol 1993; 119:756.",
"       </li>",
"       <li>",
"        White, J; et al. Clin Oncol 2004; 16:159.",
"       </li>",
"       <li>",
"        Posner, M; et al. Cancer 1982; 50:2261.",
"       </li>",
"       <li>",
"        Hill, M; et al. Oral Oncol 1997; 33:275.",
"       </li>",
"       <li>",
"        Ruzich, J; et al. Head Neck 2002; 24:406.",
"       </li>",
"       <li>",
"        Airoldi, M; et al. Anticancer Res 2000; 20:3781.",
"       </li>",
"       <li>",
"        Laurie, SA; et al. Cancer 2010; 116:362.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33581=[""].join("\n");
var outline_f32_50_33581=null;
var title_f32_50_33582="Maisonneuve fracture";
var content_f32_50_33582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F80672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F80672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Maisonneuve fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 220px; height: 516px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior radiograph shows an oblique proximal fibular fracture (arrows). When this results from an ankle injury with concomitant rupture of the tibiofibular syndesmosis, it is referred to as a Maisonneuve fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33582=[""].join("\n");
var outline_f32_50_33582=null;
var title_f32_50_33583="Monofilament in diabetic foot";
var content_f32_50_33583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Monofilament estimation of pressure sensation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Use of the monofilament pressure esthesiometer for quantitative assessment of the cutaneous pressure perception threshold in the foot. The filament (arrow) is placed at a right angle to the skin on the plantar surface of the foot; pressure is then gradually increased until the filament buckles, indicating that a known amount of pressure (determined by the stiffness of the filament) has been applied. The patient is asked if the pressure has been felt. Diabetic patients with insensitivity to the monofilament are at increased risk for foot ulcers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David McCulloch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_50_33583=[""].join("\n");
var outline_f32_50_33583=null;
